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ABSTRACT 
INTRACELLULAR MEMBRANE ORGANIZATION IN MYCOBACTERIA 
 
FEBRUARY 2017 
 
JENNIFER M. HAYASHI 
 
B.S., UNIVERSITY OF CALIFORNIA, DAVIS 
 
Ph.D., UNIVERSITY OF MASSACHUSETTS AMHERST 
 
Directed by: Professor Yasu S. Morita 
 
Mycobacterium is a diverse genus of actinobacteria that includes the causative 
agents of human tuberculosis and leprosy. Mycobacteria are protected by their unique, 
multilaminar cell envelope, w hich grants them intrinsic resistance to environmental 
challenges such as antibiotics. This essential cellular structure is elongated at the polar 
ends of cells, but the regulation of cytosolic precursor synthesis and localized envelope 
synthesis remains unclear. Here, w e present the PMf (plasma membrane free of cell w all 
components), a membrane domain distinct from the bulk plasma membrane of 
Mycobacterium smegmatis. Proteomic and lipidomic characterization demonstrate that 
the PMf contains lipidic substrates of cell envelope synthesis as w ell as the essential 
enzymes that produce these lipids. Live imaging of cells expressing PMf-targeted 
fluorescent reporters reveals that the PMf is enriched near the site of new  cell envelope 
synthesis and is present upon the formation of a new  grow th pole. Additionally, w e found 
 vii 
that during nutrient starvation and antibiotic treatment, the PMf redistributes from the cell 
poles to the sidew all of the cell body, suggesting its role in general cell envelope 
maintenance. These observations support a model in w hich the PMf functions to 
spatiotemporally coordinate cell elongation by providing the necessary precursor 
molecules at the site of envelope synthesis.  
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 1 
CHAPTER 1 
MYCOBACTERIA, DISEASE, GROWTH, AND THE PMf 
1.1 Tuberculosis 
1.1.1 A brief history 
Mycobacterium tuberculosis is the causative agent of human tuberculosis, an 
infection that is slow  progressing, w ith periods of latency and reactivation. Using these 
disease characteristics, mathematical modeling, and large scale genome analyses, 
researchers have proposed that the human pathogen interaction began around 70,000 
years ago (Chisholm et al. 2016, Comas et al. 2013).  The oldest evidence of the M. 
tuberculosis complex w as from a Pleistocene bison fossil in a Wyoming cave dated to 
more than 17,000 years ago (Rothschild et al. 2001). Evidence of tuberculosis in 
humans has been reported in Egyptian mummies dating back 3,500 years (Zink et al. 
2003) and in human remains in Peru from over 1,000 years ago (Bos et al. 2014). The 
global distribution of the pathogen has been attributed to the early human migration out 
of Africa and the subsequent expansion of the human population (Comas et al. 2013)  
Throughout human history, the host-pathogen relationship remained constant 
leading many to believe that the disease w as passed hereditarily w ithin a family. It w as 
not until the end of the Nineteenth Century that Robert Koch demonstrated the bacilli 
cultivated from tuberculous lesions lead to new  primary infections in animals (Wishnow  & 
Steinfeld. 1976). In 1943, Selman A. Waksman and colleagues discovered the anti-
microbial properties of streptomycin, beginning the era of chemotherapy against M. 
tuberculosis (Jones et al. 1944).  
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1.1.2 Global impact 
While the societal impact of tuberculosis initiated some of the first public health 
programs in history, M. tuberculosis remains a global public health concern w ith an 
estimated one third of the w orld’s population latently infect today. This disease w as 
responsible for an estimated 1.8 million deaths in 2015, making it the deadliest infectious 
disease, even more than malaria and HIV/AIDs (WHO. 2016). In 2015, an estimated 
580,000 new  cases of drug resistant (at least rifampicin-resistant) tuberculosis w ere 
reported in the w orld, a 17% increase from 2014 reports (WHO. 2015). The increase in 
drug resistant cases and the persistence of the disease around the w orld, demonstrate 
the need for new  methods of treating this disease. 
1.1.3 Disease prevention 
Historically, the primary method to prevent the spread of tuberculosis w as 
isolation of patients presenting w ith active disease, this lead to the establishments of 
sanatoriums (Wishnow  & Steinfeld. 1976). First used in 1921, the BCG (bacillus 
Calmette-Guérin) vaccine, developed by Calmette and Guerin, is a live-attenuated strain 
of Mycobacterium bovis. It is highly effective in preventing childhood tuberculosis 
(meningitis and milliary) infections w ith an efficacy of 60-90%, how ever, in other 
populations, the vaccine has been show n to be ineffective (Husain et al. 2016). Despite 
the variable efficacy, in 2015, 157 countries recommended universal BCG vaccination 
w ith a majority of those countries reporting greater than 90% coverage of the population 
(WHO. 2016). Unfortunately, the search for improved vaccines has been slow  to 
progress w ith 13 candidate vaccines currently under testing but none are expected to be 
used in the near future (WHO. 2016).  
1.1.4 Treatment 
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Since the discovery of streptomycin in 1944, many other chemotherapies have 
been used against M. tuberculosis infections, the most recent being bedaquiline, w hich 
has made it through Phase II clinical trials and  w as conditionally approved for use in the 
United States in 2012 (Zumla et al. 2013, WHO. 2012, Diacon et al. 2009) How ever the 
current recommended treatment of active tuberculosis disease requires four first line 
drugs (Isoniazid, INH; Rifampin, RIF; Ethambutol, EMB; Pyrazinamide, PZA) to be 
administered daily for a minimum of tw o months, follow ed by an additional four to five 
months of daily INH and RIF doses (CDC. 2003). Isoniazid targets mycobacterial fatty 
acid synthesis, rifampicin inhibits transcription, ethambutol abrogates arabinogalactan 
synthesis, and the mechanism of action of pyrazinamide remains unclear (Zumla et al. 
2013). This cocktail of drugs is bactericidal on actively grow ing cells, but are 
bacteriostatic w hen cell enter into quiescence. In addition, patient compliance poses 
public health issues, as lack of treatment observance often leads to the generation of 
pathogen resistance. With a significant portion of the w orld’s population and the rise of 
drug resistance emphasizes the need to understand the biology to the pathogen to 
combat the disease.  
1.1.5 M. tuberculosis evasion of immune clearance 
M. tuberculosis is deposited, via small aerosol droplet, deep into the host lung 
w here alveolar macrophages engulf the pathogen (Stew art et al, 2003, Cambier et al, 
2014). M. tuberculosis avoids MyD88 activated anti-microbial upper respiratory 
macrophages, by masking their normal pathogen-activated molecular patterns (PAMPS) 
w ith phthiocerol dimycocerosate (PDIM) lipid masking (Cambier et al, 2014). Instead, M. 
tuberculosis induces expression CCL2, a macrophage chemokine, w ith its surface lipid 
phenolic glycolipid (PGL). Macrophages then signal the recruitment of other alveolar 
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macrophages to generate an innate granuloma w hich with time matures into a complex 
structure to contain the invading pathogen (Cambier et al, 2014). When in the 
macrophage virulent bacteria inhibit the production of prostanoid and cyclooxygenase 2 
by inducing the production of lipoxin A 4. This cascade leads to the prevention of plasma 
membrane repair and to mitochondrial damage w hich eventually leads to host necrosis 
and enables pathogen escape and dissemination (Behar et al. 2010).  
In addition, M. tuberculosis replicates in the host macrophage. Although reports 
of non-acidified and acid phagosome localization exist, it can be concluded that M. 
tuberculosis has some basal level of acid tolerance, and also uses its ESX-1 secretion 
system to permeabilize and escape the phagosome (Cambier et al. 2014). In immune 
competent hosts, granuloma confinement leads to sterilization of the invading pathogen, 
how ever, mycobacteria have developed methods of adapting and even thriving in this 
oligotrophic environment (Cosma et al. 2004). It is know n that granulomas are an 
aggregate of macrophages, w hile designed to w all off the pathogen in a contained 
structure, granulomas also provide a location for extensive bacterial replication (Connolly 
et al. 2007). The ESX-1 system is also used to induce the expression of host matrix 
metalloproteinase 9 w hich recruits more macrophages to the granuloma, furthering the 
maturation of the granuloma (Cambier et al. 2014).  
1.2 Mycobacterium cell envelope and growth 
 Despite their Gram positive classification, mycobacteria are protected by a 
multilaminar cell envelope, comparable to that of a Gram negative bacterium. 
Surrounding their plasma membrane, mycobacteria have a cell w all composed of layers 
of peptidoglycan covalently linked to a mesh of arabinogalactan. The cell w all is bound 
to and protected by a thick, w axy outer membrane (the mycomembrane), made of 
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mycolic acids and glycolipids. Unlike the model organisms Escherichia coli and Bacillus 
subtilis which add new  envelope matrix components along the side w all of the cell 
column, mycobacteria restrict cell envelope biosynthesis to the polar ends. It has been 
demonstrated, using cell w all dyes, that mycobacteria elongate from their poles (Aldridge 
et al, 2012, Santi et al, 2013) and using biorthogonal labeling that de novo peptidoglycan 
synthesis is restricted to designated sites at the cells pole (Meniche et al. 2014). In 
addition, many elongation complex proteins have been localized to the grow th pole, 
including Wag31 (DivIVA homologue), PonA1, and Cw sA (Meniche et al. 2014, Kieser et 
al. 2015, Plocinski et al. 2012). Unlike E. coli and B. subtilis, mycobacteria lack the 
tubulin homologue MreB, w hich is know n to help direct peptidoglycan synthesis in these 
other model organisms. This leaves the unansw ered question of how  the elongation 
complex is formed and organized at the grow th pole. 
1.2.1 Mycolic acids 
 The mycomembrane is a characteristic feature of the outer surface of 
mycobacterial cells. It is accredited for giving mycobacteria their w ax-like exterior w hich 
imparts inherent resistant to many environmental challenges such as host immune 
response and chemicals (Takayama et al. 2005, Marrakchi et al. 2014). Mycolic acids 
are composed of tw o major structural components, a long fatty acid chain know n as the 
-branch, and the meromycolic chain. The -branch is synthesized by the eukaryotic-
like fatty acid synthase I (FAS-I) w hich generates C16-C18 and C24-C26 fatty acid chains 
by the tw o-carbon unit additions to the acyl group. The meromycolic backbone is made 
by fatty acid synthase II (FAS-II); this bacteria-like complex passes the nascent fatty acid 
chain betw een a series of soluble enzymes, including AcpM, FabD, FabH, MabA, 
HadAB, HadBC, InhA, and KasA. These enzymes add tw o-carbon units to malonyl-CoA, 
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generating a longer fatty acid after each cycle, a process that is repeated until a 
designated chain length is achieved. Other enzymes further modify the meromycolic 
chain w ith double bonds, methyl groups, and cyclopropyl groups to generate specific 
mycolic acids designated by their stereochemistry. Upon the synthesis of the a-branch 
and the meromycolic branch, a condensation reaction is mediated by Pks13 before 
being transited translocated by MmpL3 to the outer membrane w here it is incorporated 
into the cell w all complex by Ag85 (Takayama et al. 2005, Marrakchi et al. 2014). 
1.2.2 Arabinogalactan 
 The linker unit of the arabinogalactan structure acts as the attachment to the 
peptidoglycan layer. Know n as glycolipid 2 (GL2), the linker unit is a decaprenylated 
GlcNAc w ith an attached rhamnose residue. The initial prenylation is performed by 
WecA and the rhamnosylation by WbbL (Angala et al. 2014, Alderw ick et al. 2015). 
Another component of the arabinogalactan layer of the mycobacterial cell w all is a long 
galactan chain synthesized by the concerted efforts of Glf, GlfT1 and GlfT2. This sugar 
chain is synthesized in the cytosol and made of repeating units of 6-D-Galfb1-5-D-Galfb. 
The galactan chain is then modified w ith arabinan chains by AftA, AftB, EmbA, and 
EmbB in the periplasmic space. The arabinogalactan complex is attached to the 
peptidoglycan by phosphodiesterase bonds onto the muramyl moiety of the 
peptidoglycan mesh (Angala et al. 2014, Alderw ick et al, 2015). 
1.2.3 Peptidoglycan  
 In mycobacteria, like many other bacteria, cytosolic peptidoglycan synthesis 
results in the generation of the cell w all intermediate Lipid II. This essential component is 
made of a prenylated disaccharide backbone of N-acetyl glucosamine-N-acetyl muramic 
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acid (NAG-NAM) bound by a pentapeptide moiety composed of L-alanine-D-glutamic 
acid-meso-diaminopimelate-D-alanine-D-alanine (Keiser and Rubin, 2014, Alderw ick et 
al, 2015, Mahapatra et al, 2005). Lipid II is synthesized by a group of enzymes know n as 
MurA through G, w ith MurA generating the carbohydrates and MurG adding the prenyl 
group as the final step. Upon synthesis, Lipid II is translocated across the plasma 
membrane by an unknow n flippase (proposed to be MviN) w here penicillin binding 
proteins (PBPs) incorporate the molecule into the existing sacculus by their 
transglycosylase and transpeptidase activities (Keiser et al, 2014, Alderw ick et al, 2015). 
1.3 PIM biosynthesis  
Like the Gram positive lipoteichoic acids or the Gram negative 
lipopolysaccharide, mycobacteria also have unique lipid anchored glycan structures, 
phosphatidylinositol mannosides (PIMs) and lipomannan/lipoarabinomannan (LM/LAM). 
These inositol-anchored glycolipids are know n to be surface expressed and necessary 
for virulence in tuberculosis infections. These molecules are synthesized by the 
sequential addition of mannose residues to the inositol head of the phospholipid. 
Creating the final products of acylated phosphatidyl-myo-inositol (PI) dimannoside (2 
mannoses) and hexamannoside (6 mannoses), or AcPIM2 and AcPIM6, respectively 
(Korduláková et al. 2003, Guerin et al. 2009 A/B, Guerin et al. 2010, Morita et al. 2004). 
AcPIM4 presents a branch point in the PIMs/LM/LAM biosynthesis pathw ay. In one 
direction, PimE can act as an alpha-1-6 mannosyltransferase (Morita et al. 2006) for the 
synthesis of AcPIM6, or in the other direction MptA can elongate the mannose chain by 
an addition of an alpha-1-2 mannose to generate LM or LAM (Sena et al. 2010).  
LM and LAM are important glycolipids of the mycobacterial cell envelope as they 
are proposed act as structural support and are important for M. tuberculosis virulence 
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(Fukuda et al. 2013). It has been demonstrated that changes in the structure of LM/LAM 
alters the host-pathogen relationship, as they are thought to be important modulatory 
molecules of the immune response (Angala et al. 2014, Kaur et al. 2014). While their 
placement in the outer or inner membrane and their transport betw een the plasma 
membrane and outer membrane remain unknow n, it has been determined that these 
glycolipids are important for cell survival. 
1.4 The PMf 
Previously, w e demonstrated that density fractionation of Mycobacterium 
smegmatis cell lysate isolated tw o membrane fractions, know n as the Plasma 
Membrane free of cell w all (PMf) and the Plasma Membrane w ith Cell Wall (PM-CW; 
Morita et al, 2005). We determined that structural phospholipids (PI; 
phosphatidylethanonlamine, PE; cardiolipin, CL) w ere evenly distributed betw een these 
tw o membrane fractions. How ever, the enzyme that decarboxylates phosphatidylserine 
(PS) making PE (PS decarboxylase) w as enriched in the PMf fractions. Using cell-free 
radiolabeled substrate assays, w e determined that the PIM biosynthetic pathw ay, from 
PI to AcPIM6 w as compartmentalized betw een the PMf and the PM-CW. The enzymes 
and products involved in the synthesis of PI to AcPIM2 w ere found in the PMf w hile 
those used to synthesize from AcPIM2 to ACPIM6 w ere found in the PM-CW (Morita et 
al. 2005). In addition, the mechanisms of action of the PIM/LM/LAM biosynthetic  
enzymes dictate differential localization of these processes. For example, the enzymatic 
processes found in the PMf use cytosolically available GDP-mannose, w hile those in the 
PM-CW utilize polyprenylphosphate mannose (PPM), a membrane bound mannose 
donor (Scherman et al. 2009, Kaur et al. 2014, Fukuda et al. 2013, Sena et al. 2010, 
Guerin et al. 2010, Guerin et al. 2009a, Guerin et al. 2009b, Morita et al. 2004, 
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Korduláková et al. 2003). From this study, w e concluded that the PMf w as a 
biochemically isolatable membrane fraction in the model organism M. smegmatis that 
contains lipid biosynthetic properties. 
1.5 Goal of this Study 
This study aims to bridge the gap betw een the spatiotemporal control of 
mycobacterial elongation and the PMf. Previously, it w as known that mycobacteria grow  
at their polar ends by adding new  cell envelope components at restricted locations. In 
addition, w e demonstrated that the synthesis of a subset of these cell envelope 
components is biochemically separated betw een tw o novel membrane fractions. 
Therefore, w e hypothesized that the synthesis of the PIMs and related molecules occurs 
at the cell poles. We address this hypothesis by answ ering the follow ing questions: 
1) What is the PMf? 
2) What happens to the PMf w hen cells are not elongating? 
1.6 Significance and Contribution of this study 
Mycobacterium is a family of bacteria that includes a number of dangerous 
pathogens. Arresting the grow th of mycobacteria may be possible through the disruption 
of control points that regulate cell envelope biosynthesis. We demonstrate that 
Mycobacterium smegmatis possesses a spatially distinct biosynthetic membrane domain 
enriched in the polar grow th region of the cell. This membrane domain may act as an 
organizing center to spatiotemporally coordinate biosynthetic activities during grow th in 
live cells. Thus, our findings provide an important insight into the potential regulatory 
mechanisms of lipid metabolism in mycobacteria. 
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1.7 Dissertation Overview 
Follow ing this introduction, Chapter 2 begins the characterization of the PMf as a 
multifunctional membrane domain found at the grow th pole.  Using comparative 
proteomic and lipidomic analyses w ith biochemical confirmation and in vivo live cell 
imaging, w e are able to characterize the PMf in logarithmically grow n cells, this w ork 
w as previously published in full in the Proceedings of the National Academy of Sciences 
USA as Hayashi et al. 2016. Chapter 3 addresses the question of the PMf necessity in 
non-grow ing cells. Here, w e determine that the PMf is reorganized and maintained in 
non-grow ing cells using chemical and genetic stresses in cooperation w ith fluorescent 
microscopy.  
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CHAPTER 2 
 
(Previously published in w hole in the Proceedings of the National Academy of Sciences 
in April 2016) 
SPATIALLY DISTINCT AND METABOLICALLY ACTIVE MEMBRANE DOMAIN IN 
MYCOBACTERIA 
2.1 Introduction 
Tuberculosis caused by the infection of Mycobacterium tuberculosis (Mtb), is a 
disease that claims about 1.5 million human lives annually (1). The thick, lipid-laden cell 
envelope of mycobacteria is composed of a plasma membrane, peptidoglycan- 
arabinogalactan layer, and mycolate outer membrane that are crucial for pathogenicity 
(2–4). The cross-sectional structure of the five or more distinct layers that form static 
mycobacterial cell envelope has been elucidated (2, 5). How ever, any mechanism for 
lateral elongation of a multilayered structure has not been defined. Most models posit 
that key components are synthesized inside the plasma membrane, w ith subsequent 
transport to outer layers of elongating cell w all (CW) (6). In mycobacteria, the elongation 
of the cell envelope is restricted to the polar region of the cell (7–10), suggesting the 
presence of spatiotemporal control mechanisms to supply cell envelope biosynthetic 
intermediates to this region (6). Indeed, a recent study demonstrated that key bio- 
synthetic enzymes of the peptidoglycan-arabinogalactan-mycolic acid core structure are 
specifically enriched in the subpolar region of mycobacterial cells (11).  
We previously reported membrane compartmentalization in Mycobacterium 
smegmatis (Msmeg) (12). Density gradient fractionation of mycobacterial lysate revealed 
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a distinct fraction containing plasma membrane free of the CW (PMf) in addition to a 
fraction containing the classical plasma membrane tightly associated w ith the CW (PM-
CW). Both of these membranes are composed of major phospholipids such as 
phosphatidylethanolamine (PE), phosphatidylinositol (PI), and cardiolipin (12). How ever, 
the PMf fraction is enriched in specific enzymes related to the biosynthesis of PE and PI 
mannosides (PIMs) (12), implying its distinct role in phospholipid metabolism. To 
synthesize phospholipids, mycobacteria use the cytidine diphosphate- diacylglycerol 
(CDP-DAG) pathw ay (13), in w hich phosphatidic acid (PA) is activated to CDP-DAG, 
and then converted to phosphatidylserine and PI (14). PE is produced from 
phosphatidylserine by phosphatidylserine decarboxylase (Psd), and this enzyme activity 
is enriched in the PMf (12). PIMs are made by sequential additions of mannose onto a 
PI, and AcPIM2 and AcPIM6, containing tw o and six mannose residues, respectively, 
are tw o major products. Although these mature PIM species are distributed in both the 
PM- CW and PMf, the enzymatic activities from PI to AcPIM2 and from AcPIM2 to 
AcPIM6 are enriched in the PMf and the PM-CW, respectively (12). Furthermore, PimB′, 
the mannosyltransferase that mediates the second mannose addition (15, 16), is 
specifically associated w ith the PMf (17). In addition, polyprenol-phosphate- mannose 
(PPM) is a lipidic mannose donor critical for the synthesis of mannose-containing 
glycolipids such as AcPIM6, lipomannan, and lipoarabinomannan. PPM synthase, 
composed of Ppm1 and Ppm2, is essential for survival (18), and its activity is also 
enriched in the PMf (12). Hence, biosynthetic reactions critical for cell envelope 
biosynthesis are associated w ith the PMf. How ever, w hether these enzymes are 
specifically bound to the PMf and w hether the PMf is a spatially distinct membrane in 
vivo remained un- determined. In the current study, w e combined large-scale analytical 
methods w ith live-cell imaging. Our data reveal the broader composition of a 
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spatiotemporally distinct membrane domain, demonstrating colocalization of enzymes 
w ith the products of lipid pathw ays in w hich they operate. These data support the idea 
that the PMf is an organizing center for the biosynthesis of specific metabolites in 
mycobacteria. 
2.2 Results 
2.2.1 The PMf Is a Multifunctional Membrane 
To broadly understand the protein composition of the PMf, w e conducted a 
comparative proteomic analysis and identified a total of 240 and 626 proteins enriched in 
the PMf and the PM-CW, respectively (Dataset S1). We used the DAVID gene functional 
classification tool (19) to reveal enrichment of the transport and metabolic machineries of 
inorganic ions, amino acids, and carbohydrates in the PM-CW (Supplemental materials, 
Fig. 2.S.1). The PM-CW w as also enriched in enzymes involved in protein trafficking, 
energy metabolism, and signal transduction (Table 2.S.1). Our proteomic analysis 
extends the key conclusion of our previous study that the PM-CW is the classical plasma 
membrane tightly bound to the CW. In contrast, the PMf w as enriched in proteins 
involved in metabolism of specific cell envelope components (Supplemental materials, 
Fig. 2.S.1). As predicted, w e observed PimB′ (MSMEG_4253), Psd (MSMEG_0861), 
and Ppm1 (MSMEG_3859) in the pool of 240 PMf-enriched proteins, validating our 
analysis. Only eight of 240 PMf proteins w ere predicted to have transmembrane (TM) 
domains (Table 2.S.2) (20), suggesting that most PMf-associated proteins are peripheral 
membrane proteins.  
Five of the new ly identified PMf-associated proteins w ere chosen for further 
analysis based on know n or predicted function, abundance, protein size, and the 
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presence of a TM domain (Fig. 2.S.2 ). They w ere GlfT2 (MSMEG_6403, UDP- 
galactosyltransferase), Gtf1 (MSMEG_0389, glycosyltransferase), a geranylgeranyl 
reductase (MSMEG_2308), PyrD (MSMEG_4198, dihydroorotate dehydrogenase), and 
a putative membrane protein (MSMEG_1944), of w hich the last tw o have predicted TM 
do- mains. We expressed these proteins w ith a C-terminal HA tag in w ild-type M. 
smegmatis (Fig. 2.S.15A for the vector design). Western blotting of density gradient 
fractions show ed that all the selected proteins w ere enriched in the PMf fractions, 
colocalizing w ith an endogenous PMf marker PimB′ (Fig. 2.1A, Fig. 2.S.2A).  
Further analysis of GlfT2 and PyrD show ed that both GlfT2-HA and PyrD-HA 
coimmunoprecipitated w ith PimB′ from crude lysate (Fig. 2.1B and Fig. 2.S.2B). The 
coimmunoprecipitation (IP) of PimB′ w as dependent on the HA epitope tag (Fig. 2.S.2C). 
MptA (MSMEG_4241), a PM-CW mannosyltransferase involved in the biosynthesis of 
lipomannan and lipoarabinomannan (17), w as not pulled dow n under the same 
conditions, and mild detergents disrupted the co-IP of PimB′, consistent w ith the idea 
that the PMf membrane mediates these protein interactions. Previously, negative-stain 
transmission electron microscopy (TEM) revealed vesicle-like structures in the PMf 
fractions (12), termed PMf vesicles. Immunogold TEM revealed both GlfT2-HA and 
PimB′, detected by anti-HA and anti-PimB′ antibodies, respectively, on the same PMf 
vesicles, reinforcing the co-IP results (Fig. 2.1C). Of 60 randomly chosen vesicles, 44 
vesicles w ere detected by at least one of the antibodies, and 10 vesicles w ere detected 
by both (Fig. 2.1D). Control experiments established the specificity of this detection (Fig. 
2.1D and Fig. 2.S.3A–E). Taken together, these data indicate the PMf is a 
multifunctional mem- brane bound by a specific set of proteins w ith know n functions.  
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2.2.2 The Refined Proteome Indicates the Roles of the PMf in Lipid Metabolism 
and Cell Envelope Biogenesis  
Many PMf proteins w ere categorized as having know n functions in DNA 
replication and protein translation, rather than membrane biogenesis (Fig. 2.S.1). In 
addition, GlnA1 (MSMEG_4290), an abundant glutamine synthetase in mycobacteria 
(21) that forms a ∼600-kDa homododecamer (22), w as highly enriched in the PMf 
(Dataset S1). How ever, w hen GlnA1-HA w as expressed, it did not colocalize w ith nor 
coimmunoprecipitate PimB′ (Fig. 2.S.2A, D, and E). Thus, large cytoplasmic protein 
complexes, such as GlnA1 and those involved in DNA replication and protein translation, 
contaminated the PMf fraction, likely as a result of overlapping sedimentation properties.  
We established an epitope tag-based purification system to remove contaminants by 
creating a transgenic Msmeg strain w ith the endogenous glfT2 gene replaced w ith an 
mCherry (mC) fusion gene, HA-mC-glfT2 (Fig. 2.S.15B). GlfT2 is an essential 
galactosyltransferase for arabinogalactan biosynthesis (23–25). Transgenic and w ild-
type strains grew  at similar rates (Fig. 2.S.4A), suggesting that HA-mC-GlfT2 replaces 
the function of the w ild-type protein. After confirming the specific PMf localization of HA-
mC-GlfT2 (Fig. 2.S.4B), w e purified the PMf by density gradient fractionation, follow ed 
by anti-HA IP, and performed comparative proteomics on this and an identically treated 
w ild-type sample. Using a stringent criterion of 10-fold enrichment in the PMf from HA-
mC-GlfT2-expressing cells, w e detected 309 PMf-associated proteins (Dataset S1). 
Among them, 117 w ere present in the initial PMf proteome, including previously 
characterized PimB′, PyrD, Ppm1, Gtf1, Psd, geranylgeranyl reductase, and 
MSMEG_1944. Importantly, w e no longer detected GlnA1 or other suspected 
cytoplasmic contaminants. Instead, the PMf w as reaffirmed as a membrane enriched in  
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Figure 2.1. GlfT2-HA and PimB’ are bound to the same PMf membrane 
(A) Western blot of density gradient fractions of GlfT2-HA-expressing cell lysate. GlfT2-
HA (74.9 kDa -HA) and endogenous PimB’ (41.4 kDa, -PimB’) co-localize to the 
fractions 4-6, suggesting that GlfT2 is a PMf-associated protein. MptA (54.3 kDa, -
MptA) indicates PM-CW fractions. (B) Co-IP of GlfT2-HA and endogenous PimB’ and its 
disruption by mild detergent, suggesting the membrane-mediated interaction. Input is the 
equivalent amount of cell lysate used in co-IP experiment w hile, HES (HEPES, pH 7.4, 
EDTA, NaCl) and HESD (HES w ith mild detergents) indicate buffers used. (C) Negative 
staining immuno-EM of the PMf from GlfT2-HA expressing cells illustrating co-
localization of GlfT2-HA (5 nm gold, open arrow heads) and endogenous PimB’ (10 nm 
gold, close arrow heads). Bar, 100 nm. (D) Quantification of immunogold-labeled GlfT2-
HA expressing PMf vesicles treated w ith (as in panel C) or w ithout (as a negative 
control) primary antibodies. None, no gold particle detected on a vesicle; HA, one or 
more 5 nm gold particles detected; PimB’, one or more 10 nm gold particles detected; 
Both, at least one 5 nm and one 10 nm gold particle detected. N = 60. 
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proteins involved in cell envelope biogenesis and lipid metabolism, as w ell as trans- port 
and metabolism of secondary metabolites, amino acids, and inorganic ions (Fig. 2.S.4C). 
Notably, w e found acyltransferase MSMEG_2934 involved in AcPIM2 biosynthesis, 
consistent w ith previous findings that the early steps of PIM biosynthesis take place in 
the PMf (12). In addition, w e found putative DAG kinases (MSMEG_4335 and 
MSMEG_1920; the orthologs of Mtb Rv2252 and Rv3218) (26) and 1-acylglycerol-3- 
phosphate O-acyltransferase (MSMEG_4248; the ortholog of Mtb Rv2182c) (27, 28) 
enriched in the PMf. These enzymes function in tw o independent pathw ays of PA 
biosynthesis, indicating the possibility that the PMf is the site of PA production, a 
hypothesis investigated in detail later. Collectively, proteomic analysis indicated the PMf 
as a specialized membrane–protein complex w ith defined and interrelated metabolic 
functions.  
2.2.3 Comparative Lipidomics Supports Specialized Biosynthetic Function of the 
PMf 
Selective association of lipid biosynthetic enzymes w ith the PMf suggested that 
the lipid composition of the PMf and PM-CW might be different. Using an established 
normal phase HPLC-mass spectrometry (MS) platform and mycobacteria-specific ion 
databases (29, 30), w e completed comparative lipidomics analysis of the PMf and PM-
CW. Biological quadruplicate analyses detected 11,079 molecular events, w hich 
represent linked m/z, retention time, and intensity values (Fig. 2.2A). After aligning 
datasets as paired events w ith equivalent mass and retention time values and 
calculating ion intensity ratios for all pairs, w e enumerated the molecular events that 
changed in intensity above a high threshold value (tw ofold, Benjamini-Hochberg 
corrected P < 0.05). We found 642 and 796 events that w ere significantly over- 
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represented in the PMf and PM-CW, respectively (Fig. 2.2A and Datasets S2 and S3). 
Thus, 13% of all lipids met this stringent change criterion, demonstrating broad 
differences in lipid com- position of the tw o fractions.  
2.2.4 Identification of Altered Lipids  
The m/z and retention time values embedded in changed events could be used to 
identify the bio- chemical identities of key lipids corresponding to the changed events. 
Because the large number of changed events (1,438) precluded identification of all lipids 
by collision-induced dissociation MS (CID-MS), w e used recently validated methods to 
prioritize events for biochemical analysis (31, 32). These criteria included detection of 
multiple isotopes of the same molecular ion (M) or mass intervals characteristic of alkane 
series w ith more than one member detected. We further focused on the abundant 
mycobacterial membrane phospholipids in the MycoMass and MycoMap databases (29), 
using their reported m/z and retention time values for preliminary identifications of 
matching ions (Fig. 2.2A). Tentative identifications obtained by database matching w ere 
validated using CID-MS analysis for at least one member of each class (Fig. 2.2 B–F; 
Figs. 2.S.5–S.9 and Table 2.S.3, indicated by CID-MS Y; Table 2.S.4). Other members of 
the indicated class w ere assigned w hen nearly identical retention times and mass 
variations typical of acyl chain length or unsaturation w ere detected (Table 2.S.3, indicated 
by CID-MS N).  
Major phospholipid species such as PI (35:0; i.e., 35 carbon chain w ith no 
unsaturated bond) and PEs (3:2, 34:1, 34:2, and 35:0) (33) w ere equally distributed 
betw een the PM-CW and the PMf (Fig. 2.2A and B and Fig. 2.S.5 and Tables 2.S.3 and 
2.S.4), consistent w ith previous TLC analysis (12). Consistent w ith the previous 
observations that the biosynthetic steps after AcPIM2 take place in the PM-CW (12), 
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AcPIM3 species w ere enriched in the PM-CW fraction (Fig. 2.2A and D and Fig. 2.S.7 
and Table 2.S.3). We also found three acyl forms of AcPIM2 enriched in the PM-CW, 
suggesting that inositol acylation to produce tetra-acyl PIMs may take place in the PM-
CW as w ell. In contrast, the PMf is enriched in lipid species that are likely involved in 
core glycerolipid metabolism. Notably, w e found four PA species (32:1, 34:0, 34:1, 34:2) 
enriched in the PMf (Fig. 2.2A and F and Fig. 2.S.9 and Tables 2.S.3 and 2.S.4). This 
correlates w ith the enrichment of PA-producing enzymes in the PMf pro- teome, as 
described earlier. Similarly, TAGs (51:1, 52:1) w ere enriched in the PMf (Fig. 2.2A and 
E), and w e found a putative TAG synthetase (Tgs) (MSMEG_0290) enriched in the PMf 
(Dataset S1). In contrast, DAG, the substrate for Tgs, w as found in both the PMf and the 
PM-CW, although only one acyl species (34:1) could be reliably detected (Discussion). 
Taken together, despite having a similar major phospholipid com- position to the PM-
CW, the PMf is uniquely enriched in specific lipid species that correspond to the 
enzymatic content of the fraction.  
2.2.5 The PMf Exists as Discrete Patches in Live M. smegmatis Cells  
In addition to the HA-mC-GlfT2 strain described earlier, w e created a second 
strain to visualize the PMf by live-imaging fluorescence micro- copy. In this strain, 
endogenous Ppm1 w as replaced w ith the fusion protein Ppm1-mNeonGreen (mNG)-
cMyc (Fig. 2.S.15B). Ppm1 is the essential catalytic subunit of PPM synthase (18) and 
w as identified in the refined PMf proteome (Dataset S1). The transgenic strain grew  at a 
rate comparable to w ild type, implying that the fusion protein is functional (Fig. 2.S.10A). 
Furthermore, the fusion protein localized to the PMf during density gradient fractionation 
(Fig. 2.S.10B). We visualized the PMf using these strains expressing either HA-mC-
GlfT2 or Ppm1-mNG-cMyc, and show ed that the PMf formed foci of variable size and  
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Figure 2.2. Lipidomic profiling of the PMf and the PM-CW by MS reveals 
shared and distinct lipids 
(A) Volcano plot of ions detected after HPLC-MS. Individual ions (circles) detected in the 
positive and negative ion modes w ere combined and plotted based on fold-change and 
statistical significance in the PM-CW versus the PMf, using paired samples (N=4). The 
horizontal dashed line indicated P < 0.05 (Benjamini-Hochberg corrected P value); the 
vertical dashed line indicates tw ofold change. The intensity of individual points indicates 
their relative ion intensity. All lipids indicated by arrow s in A w ere subjected to CID-MS to 
identify ions of interest, w ith five representative lipids show n in B-F. PE (35:0) and PI 
w ere detected in both fractions (B and C). Monoacyl PI trimannoside (AcPIM3) w as PM-
CW enriched (D). TAG (52:1) and PA (43:2) w ere PMf-enriched (E and F). The chemical 
structures and fragments detected from tandem MS are show n. 
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intensity throughout the cells, w ith particularly intense foci at the poles (Fig. 2.3A). To 
determine w hether the fluorescent patches w ere artificial aggregates induced by fusion 
proteins (34), w e expressed GlfT2 fused w ith a monomeric mTurquoise2 (mT) in the HA -
mC- GlfT2-expressing strain (35). We confirmed PMf localization by density gradient 
fractionation (Fig. 2.S.11A) and show ed that fluorescent patterns of mT-GlfT2-FLAG 
paralleled HA-mC-GlfT2 patterns (Fig. 2.S.11B). Previously reported autofluorescence 
from w ild-type Msmeg (36) w as negligible compared w ith the fluorescence from mT-
GlfT2-FLAG expressed in w ild-type cells (Fig. S12). These data rule out common 
artifacts that sometimes occur w ith protein engineering w ithin bacterial cells and 
corroborate a method for tracking key PMf markers.  
 To compare the fluorescent patterns of the PMf and PM-CW, w e introduced a 
PimE-GFP-FLAG expression vector in the HA-mC-GlfT2-expressing strain. PimE is a 
PM-CW-associated enzyme involved in AcPIM6 biosynthesis (37), although it w as not 
identified in the PM-CW proteome, likely because it is a highly hydrophobic membrane 
protein (Dataset S1). We confirmed that PimE-GFP-FLAG w as enriched in the PM-CW-
containing fraction of density gradients (Fig. 2.S.11C). In striking contrast to HA-mC-
GlfT2 fluorescence, PimE-GFP-FLAG revealed annular fluorescent patterns, in addition 
to apparent septal fluorescence, consistent w ith the PM-CW as the classical plasma 
membrane tightly associated w ith CW (Fig. 2.3B). To examine the colocalization of the 
tw o PMf proteins, HA-mC-GlfT2 and Ppm1-mNG-cMyc, w e generated another 
transgenic strain in w hich both endogenous GlfT2 and Ppm1 w ere replaced w ith HA-
mC-GlfT2 and Ppm1-mNG-cMyc, respectively. This transgenic strain grew  at a similar 
rate to w ild type, implying functional proteins (Fig. 2.S.10A). We confirmed PMf 
localization of both proteins by density gradient  
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Figure 2.3. Live imaging of the PMf markers in M. smegmatis showing discrete 
patches of the PMf 
(A) HA-mCherry-GlfT2 (right) and Ppm1-mNG-cMyc (left) expressing cells show ing 
punctate foci often enriched at the poles of the cells. Bar = 5 μm. (B) Co-expression of 
PimE-GFP-FLAG in HA-mCherry-GlfT2-expressing cells demonstrates distinct 
fluorescent patterns of the PMf (HA-mCherry-GlfT2, arrow heads indicating polar foci) 
and the PM-CW (PimE-GFP-FLAG). Bar = 5 μm. (C) Localization of tw o PMf-associated 
proteins (HA-mCherry-GlfT2 and Ppm1-mNG-cMyc) colocalize at the polar ends of the 
cells. Bar = 5µm.  
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fractionation (Fig. 2.S.10C and D). We then show ed overlapping in vivo localization of 
these tw o proteins (Fig. 2.3C), w ith the Pearson colocalization coefficient of 0.89 ± 0.06 
(n = 20), w hich was substantially higher than the coefficient of 0.37 ± 0.16 (n = 20) for 
HA-mC-GlfT2 (PMf) and PimE-GFP-FLAG (PM-CW) show n in Fig. 3B. Thus, the PMf is 
spatially distinct from the plasma membrane in live Msmeg cells.  
2.2.6 Enrichment of the PMf Is Spatiotemporally Correlated to Actively Growing 
Poles  
Mycobacteria grow  from their polar ends, w here w e found the strongest 
enrichment of HA-mC-GlfT2 and Ppm1- mNG-cMyc foci (Fig. 2.3). Time-lapse 
microscopy of the strain expressing both PimE-GFP-FLAG and HA-mC-GlfT2 show ed 
that PimE-GFP-FLAG stably associated w ith the plasma mem- brane, w hereas HA-mC-
GlfT2 foci continuously associated w ith the grow ing poles (Fig. 2.4A and Movie S1). In 
an alternative approach, w e stained the preexisting CW w ith a fluorescent amine-
reactive dye, w ashed the dye, allow ed the cells to grow , and visualized the grow th of the 
unlabeled poles (9). We found that the unlabeled grow ing poles possessed HA-mC-
GlfT2 foci (Fig. 2.S.13). These data indicated that the PMf- associated proteins are 
enriched in the grow th pole of the cell.  
 To further test the temporal correlation of the PMf w ith polar cell envelope 
elongation, w e induced ectopic polar grow th and abnormal branching of the HA-mC-
GlfT2-expressing cells by transiently treating the cells w ith D-cycloserine (DCS). We 
found a fraction of cells initiating grow th at ectopic poles during the recovery from DCS-
induced grow th arrest (Movie S2). Importantly, HA-mC-GlfT2 w as observed at the site of 
bifurcation during branching initiation (Fig. 4B) and continuously enriched at the ectopic,  
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Figure 2.4. Live imaging of the PMf and the PM-CW demonstrates spatiotemporal 
correlation of the PMf to polar cell wall elongation. 
(A)  Frame shots of time-lapse microscopy (see Movie S1) of the PimE-GFP-FLAG/HA-
mCherry-GlfT2 dual expressing cells, illustrating the continuous enrichment of the PMf at 
the grow ing cell poles. Time (min) represents the time since the start of the recording. 
The movie w as recorded at 1800x real time speed. Bar, 10 μm. (B) Time-lapse movie of 
HA-mCherry-GlfT2 expressing M. smegmatis cells exposed to cycloserine (see Movie 
S2), show ing the correlation of new ly created ectopic polar grow th and PMf foci. The 
time indicates w hen the frame shots w ere taken in relation to the first frame. Arrows = 
branch point, arrow heads = polar ectopic grow th. Bar = 15 μm. 
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DCS-induced grow th pole. Thus, our data indicate PMf localization to the poles of 
mycobacterial cells in tw o models of grow th.  
2.3 Discussion  
Organized lipid microdomains in live mycobacteria w ere reported in 1999 (38), 
using fluorescent lipid probes. More recently, cardiolipin enrichment w as observed at the 
septa and poles of actively grow ing cells w ith the fluorescent dye 10-N-nonyl acridine 
orange (39). These studies suggested that the mycobacterial membrane is not entirely 
homogenous. How ever, the physiological significance of these observations remained 
unclear.  
In this study, w e presented three independent lines of evidence supporting the 
existence of functionally specialized membrane domain in mycobacteria. First, proteomic  
analysis identified more than 300 putative proteins that specifically associate w ith the 
PMf. Identification of PimB′, Psd, and Ppm1 verified our previous observations (12). In 
addition, PimB′, and Ppm1 are essential enzymes (16, 18), indicating the critical role of 
the PMf as a site of essential lipid biosynthetic reactions. We confirmed the PMf 
association of six proteins by density gradient fractionation and performed further 
analyses on GlfT2, Ppm1, and PyrD. GlfT2 does not contain predicted TM domains, but 
rather, its crystal structure implies peripheral membrane association (40). Extending 
previous studies show ing that GlfT2 cofractionates w ith both membrane and CW (24), 
our data demonstrated stable and specific binding of GlfT2 to the PMf membrane. In 
contrast, the membrane association of Ppm1 is mediated by the formation of a 
heterodimer w ith the membrane protein Ppm2 (41), w hich may dictate PMf localization. 
We did not detect Ppm2 in our PMf proteome, likely because of the highly hydrophobic 
nature of Ppm2. The PMf association of GlfT2 and Ppm1 predicts that the galactan 
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precursor and PPM, the products of these enzymes, may be found in the PMf lipidome. 
How ever, they are transient bio- synthetic intermediates and could not be identified by 
our current analysis. PyrD is a family 2 quinone-dependent dihydroorotate 
dehydrogenase (42) involved in pyrimidine biosynthesis. It is predicted to be essential in 
Mtb (43) and is hypothesized to interact w ith the PMf membrane through a predicted TM 
domain. Whereas precise molecular mechanisms of how  these different proteins 
associate w ith the PMf membrane remain to be determined, our data indicate that the 
PMf harbors multiple essential biosynthetic enzymes.  
Second, w e established that the PMf has a distinct lipid composition from that of 
the classical plasma membrane. We confirmed our previous observation that PE and PI, 
major phospholipid species, are equally distributed in both membrane fractions, 
suggesting that the PMf and the classical plasma membrane are formed by certain 
ubiquitous phospholipids. In contrast, all four detectable acyl forms of PA are enriched in 
the PMf, reinforcing the interpretation of the PMf as a metabolically active membrane 
w ith specialized function (Fig. 2.S.14). In addition to the PA- producing enzymes, the 
PMf proteome w as enriched in a putative glycerol phosphate acyltransferase 
(MSMEG_4703) (Dataset S1) that mediates the committed step of PA biosynthesis, 
further suggesting that glycerolipid biosynthesis initiates in the PMf (Fig. 2.S.14). 
Interestingly, a DAG species w as present in both membrane fractions, suggesting the 
subsequent reaction of TAG synthesis can take place in either membrane. Among eight 
Msmeg homologs of Mtb Tgs enzymes (44), w e found MSMEG_0290 enriched in the 
PMf, consistent w ith the enrichment of TAG species in the PMf. How ever, tw o other Tgs 
homologs, MSMEG_5242 and MSMEG_1882, w ere found in the PM-CW, suggesting 
that TAGs can be made in both membranes but does not accumulate in the PM-CW. 
Thus, our data may offer a spatially dynamic perspective on the TAG metabolism in 
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mycobacteria (Fig. 2.S.14). Regarding the PIM biosynthesis, w e could not identify 
intermediates such as PIM1 and PIM2 in the lipidome, likely because of their low  
abundance. Nevertheless, w e identified AcPIM2 biosynthetic proteins such as 
acyltransferase MSMEG_2934 and PimB′ in the PMf proteome (Fig. 2.S.14), confirming 
the previous studies suggesting that AcPIM2 is produced in the PMf (12). The absence 
of the first mannosyltransferase PimA in the PMf proteome w as expected because it is 
an amphipathic enzyme transiently associating w ith membrane by w eak ionic 
interactions (12, 45). Be- cause AcPIM2 is found in both membranes, AcPIM2 produced 
in the PMf must be distributed to the PM-CW. Although further studies are needed to 
characterize dynamic features of individual metabolic pathw ays, our current study clearly 
demonstrates the distinct lipid composition of the PMf w ith correlative association of 
specific enzymes.  
Finally, w e showed that the PMf forms spatially distinct patches w ith particular 
enrichment at the poles of live cells. We further show ed temporal correlation of PMf 
markers w ith the grow th of cell poles. Taken together, the current study provided 
evidence for the PMf as a spatiotemporally distinct membrane domain in w hich specific 
biosynthetic reactions take place. Although enriched at the pole, tw o observations 
suggest the PMf is not simply a purified cell pole. First, fluorescent patterns of the PMf 
membrane domain indicate it distributes throughout the cell as discrete patches in 
addition to polar enrichment. We speculate that these less intense nonpolar patches are 
involved in cell envelope maintenance, rather than elongation. Second, some pole-
associated proteins are not enriched in the PMf. Most notably, DivIVA, a w ell-know n 
pole-associated protein (11, 46), w as enriched in the PM-CW, rather than the PMf 
(Dataset S1). Taken together, w e conclude that the PMf is a membrane domain spatially 
distinct not only from classical plasma membrane but also from some know n polar 
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structures. We suggest that the PMf acts as an organizing center for multiple 
biosynthetic enzymes that are critical for cell envelope biogenesis in mycobacteria.  
2.4 Materials and Methods  
2.4.1 Cell culture and transformation 
Mycobacterium smegmatis mc2155 w as grown at 30° C in Middlebrook 7H9 broth 
supplemented w ith 11 mM glucose, 14.5 mM NaCl, and 0.05% Tw een-80, or at 37° C on 
Middlebrook 7H10 agar supplemented w ith 11 mM glucose and 14.5 mM NaCl unless 
otherw ise indicated. Antibiotic concentrations used w ere 100 μg/ml hygromycin (Wako) 
and 20 μg/ml streptomycin (Fisher Scientific). Plasmid constructs (prepared as described 
in, Fig. 2.S.8) w ere electroporated into M. smegmatis cells using a BTX ECM830 at 2.8 
kV, 99 μsec and 5 pulses at 1 sec intervals. Electroporated cells w ere plated onto 
Middlebrook 7H10 plates w ith appropriate antibiotics. 
2.4.2 Membrane fractionation and analysis 
Mycobacterial lysates w ere prepared, fractionated by sucrose density gradient 
and analyzed as previously described (12) (see SI Materials and Methods). For co-
immunoprecipitation, cell lysate w as diluted 1:20 in HES (25 mM HEPES pH 7.4, 2 mM 
EGTA, 150 mM NaCl) or HESD (25 mM HEPES pH7.4, 2 mM EGTA, 150 mM NaCl, 1% 
Triton X-100, 1% sodium deoxycholate) buffer, and incubated w ith 2.5% total volume of 
w ashed anti-HA agarose beads (Sigma) on a rotating w heel overnight at 4°C. Beads 
w ere washed four times w ith either HES or HESD, and bound proteins w ere eluted by 1 
mg/ml HA peptides (AnaSpec Inc, Fremont, CA) at 30°C for 15 min, tw ice. SDS-PAGE 
and w estern blotting w ere performed as before (15), w ith specific changes described in 
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SI Materials and Methods. Input sample w as the equivalent volume of cell lysate applied 
to the beads for immunoprecipitation.  
2.4.3 SDS-PAGE and western blotting 
Protein samples w ere mixed w ith a reducing sample loading buffer, denatured on 
ice, and run in a 12% SDS-PAGE gel. Proteins w ere transferred to a PVDF membrane 
(BioRad), blocked in 5% milk in PBST20 (PBS w ith 0.05% Tw een 20). Membranes w ere 
incubated w ith primary antibodies (anti-HA (Sigma), anti-PimB’ (7), and anti-MptA (7)) at 
1:2000 dilutions, w ashed in PBST20, and incubated w ith horseradish peroxidase-
conjugated secondary antibodies (Sigma) at 1:2000 dilutions. Blots w ere w ashed again 
in PBST20 and developed for chemiluminescence. Images w ere recorded using an 
ImageQuant LAS 4000mini (GE Healthcare). For w estern blotting of sucrose gradients, 
an equal volume of each fraction w as loaded into the gel. All experiments w ere repeated 
at least tw ice. The tagged protein in each fraction w as quantified from w estern blot 
images by ImageJ. The amount of tagged protein detected in the major gradient 
categories (Cytoplasm, Fr. 1-2; PMf, Fr.4-6; PM- CW, Fr. 9-11) w as summed and a 
percentage of detected tagged protein w as calculated by category. 
2.4.4 Immunoprecipitation of PMf proteins in membrane fractions 
Cell lysate (3.6 mg w et pellet equivalent in 18 μl) w as diluted 1:20 in HES or 
HESD (HES plus 1% Triton X-100 and 1% sodium deoxycholate) buffer, and mixed w ith 
2.5% total volume of anti-HA agarose beads (Sigma) pre-equilibrated w ith either HES or 
HESD. After overnight incubation at 4°C, beads w ere washed with the respective 
buffers, and bound proteins w ere eluted by 1 mg/ml HA peptides (AnaSpec Inc) at 30°C 
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for 15 min, tw ice. SDS-PAGE and w estern blotting w ere performed as before (7). All 
experiments w ere repeated at least tw ice to confirm the reproducibility. 
2.4.5 Negative staining EM 
Formvar coated, carbon Type-A grids (300 mesh Cu, Ted Pella, Redding, CA) 
w ere incubated formvar-side dow n w ith sample for 5 min, and w ashed with dilution 
buffer (PBS w ith 2% BSA) before being incubated w ith primary antibodies (anti-HA and 
anti-PimB’) for 30-60 min in a humidity chamber. After antibody incubation, grids w ere 
w ashed with dilution buffer and incubated w ith colloidal gold-conjugated secondary 
antibodies (Ted Pella) for 30 min in a humidity chamber. Finally, grids w ere w ashed in 
dilution buffer, then in w ater and stained w ith 2% uranyl acetate for 2 min. Grids w ere 
stored under desiccation for 3-5 d. Samples w ere observed using a JOEL JEM-2000FX 
Transmission Electron Microscope w ith a LaB6 electron source. Grids w ere imaged at 
15~25,000x magnification. A vesicle w as defined as an oval structure having a minimum 
short axis of 38 nm and a maximum long axis of 85 nm. Most structures w ere circular 
w ith an average diameter of 55 nm. Sixty vesicles from each grid w ere quantified for 
their antibody binding. 
2.4.6 Microscopy 
Static live cell imaging w as as previously described (34)(see SI Materials and 
Methods for details). New ly grow n cell w all w as differentiated from preexisting cell w all 
by chemical crosslinking as before (9) and intensity profiles of fluorescent probes w ere 
analyzed by contouring randomly selected 214 cells using MicrobeTracker (35), and 
quantifying using MATLAB R2012a (Mathw orks). Statistical significance w as determined 
by Student’s t-test. Standard time-lapse imaging w as as previously described (11). For 
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cycloserine treatment, cells w ere grow n overnight to logarithmic phase and then loaded 
into a custom-built constant-feed microfluidic device (9) for live cell imaging. A 
DeltaVision PersonalDV w idefield fluorescence microscope w ith solid state illumination 
and hardw are-based autofocus was used to image cells every 15 min in a controlled 
environmental chamber w armed to 30°C. Grow th medium (Middlebrook 7H9 
supplemented w ith 0.2% glycerol, 0.05% Tw een-80, and 10% ADC) w as passed through 
the microfluidic device for 10 h before treatment for 6 h w ith 40 μg/ml of D-cycloserine. 
Antibiotic treatment w as followed by an 8 h recovery period (in regular grow th medium).  
Standard time-lapse imaging w as performed as before (13). Briefly, bacteria w ere grown 
on an agar pad and images w ere taken every 15 min for a duration of 18 h using a 
DeltaVision Personal DV microscope equipped w ith an environmental chamber w armed 
at 37°C (Applied Precision).  
2.4.7 Cell wall labeling 
Msmeg cells w ere grown to logarithmic phase (OD600= 0.5-1.0), pelleted, w ashed w ith 
PBS, labeled w ith amine-reactive Alexa Fluor 488 succinimidyl esters (Invitrogen) at a 
final concentration of 0.05 mg/ml, pelleted, w ashed with PBS and replaced into fresh 
media. Cells w ere allow ed to grow  for 2.5 h at 30°C, shaking, and imaged as above. 
New ly elongated CW w as differentiated from preexisting CW by chemical staining as 
before (14) and intensity profiles of fluorescent probes w ere analyzed by contouring 
randomly selected 214 cells using MicrobeTracker (15), and quantifying using MATLAB 
R2012a (Mathw orks). Statistical significance w as determined by Student’s t-test. 
2.4.8 Induction of ectopic growth poles 
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For DCS treatment, cells w ere grown to logarithmic phase and then loaded into a 
custom-built constant-feed microfluidic device (14) for live cell imaging. A DeltaVision 
PersonalDV w idefield fluorescence microscope w ith solid state illumination and 
hardw are-based autofocus was used to image cells every 15 min in a controlled 
environmental chamber w armed to 30°C. Grow th medium (Middlebrook 7H9 
supplemented w ith 0.05% Tw een-80 and 10% ADC) w as passed through the 
microfluidic device for 10 h before treatment for 6 h w ith 40 μg/ml of DCS. Antibiotic 
treatment w as followed by an 8 h recovery in regular medium. 
2.4.9 Construction of plasmids 
Main features of each plasmid are summarized in Fig. S15.  
pYAB186 — To create an expression vector for PimE-GFP-FLAG (pYAB186), pYAB052 
(1) w as digested w ith SspI, and pEGFP-C1 (Clontech Laboratories) w as digested w ith 
EcoRI and AgeI. The EGFP fragment w as then blunt ended and ligated into the 
pYAB052 fragment.  
pYAB279, pYAB280, pYAB281, and pMUM015 — To create expression vectors for 
MSMEG_0389 (pYAB279), MSMEG_2308 (pYAB280), MSMEG_6403 (pYAB281), and 
GlnA1 (pMUM015), genes w ere amplified by PCR (Table S5), and the PCR products 
w ere then inserted by blunt-end ligation to pYAB178 after removing pimB’ gene by SspI. 
pYAB178 is a hygromycin- resistant integrative PimB’-HA expression vector (not used in 
this study), w hich is based on pMV361 (2). It w as designed so that pimB’ gene can be 
excised from pYAB178 in frame by SspI, a blunt-end 6-bp cutter. The digested fragment 
can then be used to insert other genes by blunt- end ligation to create an expression 
vector for C-terminally HA epitope-tagged fusion proteins.  
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pMUM012 — pMUM012 w as used only to clone genes encoding PyrD and 
MSMEG_1944 (pMUM023 and pMUM024, see below ). To create, pMUM011, a 
streptomycin-resistant derivative of pYAB178 (see above), w as digested w ith SspI to 
remove the pimB’ gene, and the PCR product 5’-SspI-EcoRV-glnA1-ScaI-SspI-3’ 
(restriction enzyme sites underlined in Table S5) w as inserted by blunt-end ligation.  
pMUM023 and pMUM024 — The genes encoding PyrD (pMUM023) and MSMEG_1944 
(pMUM024) w ere amplified by PCR (Table S5). pMUM012 w as digested w ith EcoRV 
and ScaI to remove an inserted gene in frame, and the PCR fragments carrying pyrD 
and msmeg_1944 genes w ere inserted by blunt-end ligation, creating expression vectors 
for C-terminally HA epitope- tagged fusion proteins.  
pMUM043 — To construct the mTurquoise-GlfT2-FLAG expression vector, the 
mTurquoise gene w as amplified from an Escherichia coli strain carrying mTurquoise 
using the primers (Table S5). The PCR product w as digested w ith MfeI and inserted into 
the MfeI site of pYAB281. We then amplified the 3’ region of GlfT2 from pYAB281 using 
the primers (Table S5) to add the FLAG tag in frame w ith the GlfT2 coding region. This 
PCR fragment as w ell as mTurquoise-inserted pYAB281 w ere digested w ith ClaI and 
PmlI and ligated together to create pMUM043.  
pMUM053 — To replace the endogenous glfT2 gene w ith a gene encoding HA-mCherry- 
GlfT2, w e amplified upstream and dow nstream regions of glfT2 using the primers show n 
in Table S5, and digested w ith AlwNI and DraIII, respectively. We also amplified 
mCherry using the primers show n in Table S5, and digested w ith DraIII. HA epitope w as 
synthesized w ith appropriate sticky ends (Table S5). All 4 fragments w ere ligated into 
pCOM1 (Tiw ari S and Jacobs WR Jr., unpublished) at Van91I sites. The resulting 
plasmid, pMUM053, w as transformed into Msmeg by electroporation, and positive 
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clones w ere isolated using hygromycin resistance marker and SacB- dependent sucrose 
sensitivity. Correct replacement of the glfT2 gene w as confirmed by PCR.  
pMUM072 — To replace the endogenous ppm1 gene w ith a gene encoding Ppm1- 
mNeonGreen-cMyc, w e amplified upstream and dow nstream regions of ppm1 using the 
primers show n in Table S5, and digested w ith AlwNI. Both fragments and Van91I-
digested pCOM1 fragment w ere ligated, resulting in pMUM070. VspI and BspTI sites 
introduced to the primers to amplify the upstream and dow nstream regions of ppm1 
(underlined in Table S5) w ere used to linearize pMUM070. We then amplified 
mNeonGreen-cMyc w ith VspI and BspTI at 5’ and 3’ ends, respectively (Table S5), 
digested w ith VspI and BspTI, and ligated into the pMUM070 fragment. The resultant 
plasmid pMUM072 w as transformed into Msmeg by electroporation, and positive clones 
w ere selected as described for pMUM053 (see above).   
2.4.10 Proteome preparation and analysis 
PMf and PM-CW proteomics samples w ere prepared by pelleting pooled sucrose 
density gradient fractions (PMf: 4-6, PM-CW: 8-10) at 100,000x g and w ashed with HES 
buffer (25mM HEPES pH7.4, 2mM EGTA, 150mM NaCl). Protein samples w ere 
separated on SDS-PAGE (12% gel) for a short distance and a gel slice containing entire 
unresolved protein band w as digested w ith trypsin or chymotrypsin. The extracted 
peptide fragments w ere then analyzed by data-dependent nano- LC ESI MS on an 
Orbitrap mass spectrometer (Thermo Scientific Q Exactive).  
The data w ere batch searched against the Msmeg proteome database, using the 
Mascot search engine (Matrix Science, London, UK; version 2.4.0). We searched the 
Msmegmatis_81012 database (6690 entries) w ith a parent ion mass tolerance of 10.0 
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ppm and a fragment ion mass tolerance of 0.050 Da. Carbamidomethyl of cysteine w as 
specified as a fixed modification. Pyro glutamic for N-terminal glutamine, oxidation of 
methionine and acetyl of the protein N-terminus w ere specified as variable modifications. 
Scaffold (version 4.3.2, Proteome Softw are Inc., Portland, OR) w as then used to validate 
MS/MS based peptide and protein identifications. Peptide identifications w ere accepted 
if they could be established at greater than 92.0% probability by the Peptide Prophet 
algorithm (4). Protein identifications w ere accepted if they could be established at 
greater than 90.0% probability and contained at least 2 identified peptides. Protein 
probabilities w ere assigned by the Protein Prophet algorithm (5). Proteins that contained 
similar peptides and could not be differentiated based on MS/MS analysis alone w ere 
grouped to satisfy the principles of parsimony. To calculate relative protein abundances, 
the exponentially modified protein abundance index (emPAI) w as used in the Scaffold 
program (6). Identified proteins w ith minimum spectral counts of 10 and a tw ofold or 
greater enrichment in either the PMf or the PM-CW w ere deemed to be part of the 
respective proteome.  
Protein identification numbers w ere input into the UniProt Retrieve/ID Mapping 
function, the UniProt Identification numbers retrieved, and subsequently subjected to 
DAVID Bioinformatics Functional Annotation tool to be classified into GO Ontology 
groups. To select the PMf-associated proteins for further biochemical analysis, w e used 
several independent criteria such as know n or predicted function in cell envelope 
biogenesis, their abundance (MS spectral counts, >20), protein size (<50 kDa), and the 
presence of a TM domain. GlfT2 (MSMEG_6403, UDP-galactosyl transferase) w as 
chosen for the abundance (spectral counts of 149 from trypsin digests) and know n 
function; Gtf1 (MSMEG_0389, glycosyltransferase) and a geranylgeranyl reductase 
(MSMEG_2308) are chosen for their predicted function, abundance (spectral counts of 
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21 and 183 from trypsin digests), and a relatively small size (46.5 and 43.1 kDa 
respectively); PyrD is a quinone-dependent dehydrogenase and w as chosen for 
abundance (spectral counts of 50 from trypsin digests), a relatively small size (37.2 
kDa), and the presence of predicted TM domain; and MSMEG_1944 w as chosen 
despite the fact that it has no know n functions because it is a unique protein in having a 
particularly small size (13.9 kDa) w ith tw o predicted TM domains.  
2.4.11 Refined PMf proteome preparation and analysis   
The PMf fractions from cells expressing HA-mCherry-GlfT2 or from w ild type 
cells w ere pooled and applied to a 10-μl bed volume of w ashed anti-HA agarose beads 
(Sigma) on a rotating w heel overnight at 4 ̊C as described above. Samples w ere then 
run in a 12% acrylamide gel for a short distance, entire unresolved protein band cut out, 
digested w ith trypsin, and analyzed by LC-ESI MS as described previously.  
The proteome data w ere analyzed as above except that the Scaffold (version 
4.4.5) w as used and peptide identification threshold w as set at 80.0% probability. To 
calculate relative protein abundances, the intensity-based absolute quantification (iBAQ) 
w as used in the Scaffold program. Identified proteins w ith minimum quantitative iBAQ 
value of 2.0x107
 
and a 10-fold or greater enrichment in the transgenic PMf sample over 
that of w ild type w ere deemed to be part of the PMf proteome. The protein identification 
numbers w ere submitted to UniProt Retrieval/ID Mapping, and the list of retrieved 
UniProt numbers w as subjected to the DAVID Bioinformatics software Functional 
Annotation program as above.  
2.4.12 HPLC-MS lipidomic analysis 
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Sucrose density gradient fractions containing either PMf or PM-CW w ere 
generated from w ild-type lysate, and subjected to chloroform/methanol/w ater (8:4:3) 
partition. The low er organic phase w as washed tw ice with chloroform/methanol/w ater 
(3:48:47). Ten percent of the volume w as removed for quantification by orcinol staining 
of TLC plates using Fiji (8), and the final organic phase w as dried under nitrogen. This 
w as repeated for four independent samples, w ith the PMf and PM-CW fraction for each 
sample treated as a pair. 
The dried samples w ere resolvated at a concentration of 1 mg lipid per milliliter in 
hexanes/isopropanol (7:3) w ith 0.1% (v/v) formic acid and 0.05% (v/v) ammonium 
hydroxide for lipidomic profiling. Samples w ere centrifuged at 2,000 rpm for 10 min prior 
to transfer to autosampler vials (Agilent). HPLC separation and MS w ere performed as 
described (9) using an Agilent Technologies 6530 Accurate-Mass Q-TOF w ith a 
monochrome diol column. Tw enty μl volumes of samples w ere injected in randomized 
order. Each set of injections w as repeated in randomized blocks in positive and negative 
ion mode tw o times, w ith additional injections performed using CID-scanning mode. 
Additional CID-MS data w ere collected w ith the same samples at energies betw een 25-
65 V.  
Raw  profile mode data w ere converted to centroid mode and mzData format 
using MassHunter (Agilent). Ion peaks w ere identified, grouped and aligned using the R 
package XCMS (10) treating positive and negative mode data separately. Zero values 
w ere replaced using random minima and samples w ere normalized by full quantiles. 
Technical replicates w ere averaged and positive and negative ion mode data joined for 
statistical analysis. The R package limma (11) w as used to identify ions meeting criteria 
for differential expression betw een the PMf and PM-CW, treating the PMf and PM-CW 
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fractions for each of the four samples as a pair. Ions w ith an adjusted p value <0.05 (12) 
and a fold-change >2 w ere considered significantly different. A complete R script for 
analysis including all XCMS and limma parameters is available as supplemental 
information (Datasets S2-S3). Ions w ere identified by matching mass and retention time 
to the MycoMap and MycoMass databases (9) follow ed by CID-MS.  
2.5 Supplemental Figures and Tables 
Datasets S1-S3, and Movies S1-S2 are published and publically available at 
http://w ww.pnas.org/content/113/19/5400.long?tab=ds 
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Table 2.S.1. Proteins identified in a manual scan as part of energy metabolism, 
lipoproteins, protein trafficking, and signal transduction in the PM-CW 
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Table 2.S.2. PMf-associated proteins with predicted TM domains 
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Table 2.S.3. Summary statistics of representative lipids 
The identity of at least one compound in each family w as established through repeat 
experiments using collision-induced dissociation mass spectrometry (CID-MS, Y). Other 
members of the indicated family w ere assigned w hen ions show ing nearly identical 
retention times and mass variations typical of alkyl change length or unsaturation w ere 
detected (CID-MS, N). 
 
 46 
Table 2.S.4. CID fragmentation of alkyl series 
Parent and CID fragments detected by mass spectrometry for ions in addition to those 
profiled in Figure 2 & Figures S5-S9.  
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Table 2.S.5. Primers to create plasmids used in this study 
Key restriction enzyme sites are underlined.  
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Figure 2.S.1. The protein populations of the PM-CW and the PMf are different 
The PM-CW is enriched in proteins involved in transport and metabolisms of 
carbohydrates, amino acids, and inorganic ions. The PM-CW also has a population of 
proteins involved in signal transduction, cell envelope biogenesis, and posttranslational 
modification. The PMf is enriched in lipid metabolism and cell envelope biogenesis. DNA 
replication and protein translational machinery are also enriched in the PMf, but these 
proteins are contaminants (see Fig. S4C).  
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Figure 2.S.2. Biochemical verification of PMf-associated proteins identified by 
proteomic analysis 
(A) Association of HA-tagged proteins to the PMf. Lysates of Msmeg cells expressing 
HA-tagged proteins w ere fractionated by sucrose density gradient, and HA-tagged 
proteins w ere detected by w estern blotting. Protein bands w ere quantified to calculate % 
distribution. (B) PyrD- HA (38.2 kDa), an HA-tagged PMf-associated protein co-
immunoprecipitates w ith endogenous PimB’, a know n PMf protein. MptA is a marker for 
the PM-CW. (C) Anti-HA agarose beads co- immunoprecipitate neither PimB’ nor MptA 
from a w ild-type cell lysate, show ing that co-IP is dependent on the HA-tagged proteins. 
(D) GlnA1-HA (54.6 kDa), a non-PMf protein, does not localize to the PMf. The PMf 
fractions are identified by the localization of PimB’ (41.4 kDa) and the PM-CW fractions 
are identified by the localization of MptA (54.3 kDa). (E) GlnA1-HA pulls dow n neither 
PimB’ nor MptA.  
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Figure 2.S.3. Immunogold labeling of Msmeg PMf fractions 
(A) Immunogold labeling of the PMf- containing density gradient fraction of GlfT2-HA 
expressing cells w ithout primary antibodies. The samples w ere labeled w ith colloidal 
gold-conjugated secondary antibodies only, and quantified as in Fig. 1D. (B) 
Immunogold labeling of the PMf-containing density gradient fraction of w ild-type (WT) 
cells w ithout primary antibodies, but w ith colloidal gold-conjugated secondary antibodies 
only. (C) Immunogold labeling of the PMf-containing density gradient fraction of w ild-type 
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cells w ith anti-PimB’ primary antibody and colloidal gold-conjugated secondary antibody. 
(D) Immunogold labeling of the PMf-containing density gradient fraction of w ild-type cells 
w ith anti- HA primary antibody and colloidal gold-conjugated secondary antibody. Bar = 
100 nm. Closed arrow heads = 10 nm gold, anti-PimB’ antibody. (E) Quantification of the 
w ild-type colloidal gold antibody staining from Figure S3B-D. None, no gold particle 
detected on vesicle; HA, one or more 5 nm gold particles detected; and PimB’, at least 
one 10 nm gold particles detected. N=60.  
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Figure 2.S.4. Replacement of the endogenous GlfT2 with HA-mCherry-GlfT2 for an 
improved PMf proteome 
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(A) Grow th curves of HA-mCherry-GlfT2 (orange) expressing cells in comparison to w ild 
type (green) demonstrates grow th is not inhibited by the gene replacement. Grow th of 
each strain w as measured in triplicate and standard deviations are show n. (B) HA-
mCherry-GlfT2 (99.6 kDa) localizes to the PMf by density gradient fractionation. The 
PMf, identified by PimB’ (41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa). (C) 
Protein function categorization of the refined PMf proteome generated from highly 
purified PMf sample by the DAVID gene functional classification tool demonstrates 
enrichment of biosynthetic processes including cell envelope and lipid biogenesis.  
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Figure 2.S.5. Ion at m/z 732.568 identified as phosphatidylethanolamine 
CID spectrum of precursor ion 732.568 labeled w ith measured m/z values and error in 
parts per million (ppm) for matches to deduced fragments that match know n values 
w ithin 10 ppm. The maximum centroid peak intensity of a single scan is show n. The 
dashed red line indicates the parent ion. Dotted blue lines indicate the masses of 
expected fragments based on the deduced chemical structure. Inset show s the chemical 
structure of PE.  
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Figure 2.S.6. Ion at m/z 851.57 identified as phosphatidylinositol 
CID spectrum of precursor ion 851.57 labeled w ith measured m/z values and error in 
parts per million (ppm) for matches to deduced fragments that match know n values 
w ithin 10 ppm. The maximum centroid peak intensity of a single scan is show n. The 
dashed red line indicates the parent ion. Dotted blue lines indicate the masses of 
expected fragments based on the deduced chemical structure. Inset show s the chemical 
structure of PI. Isomers likely exist but cannot be differentially detected by this method. 
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Figure 2.S.7. Ion at m/z 1575.95 identified as AcPIM3 
CID spectrum of precursor ion 1575.95 labeled w ith measured m/z values and error in 
parts per million (ppm) for matches to deduced fragments that match know n values 
w ithin 10 ppm. The maximum centroid peak intensity of a single scan is show n. The 
dashed red line indicates the parent ion. Dotted blue lines indicate the masses of 
expected fragments based on the deduced chemical structure. Inset show s the chemical 
structure of AcPIM3. Deduced fragment masses in the inset formatted w ith italics w ere 
not detected at < 10 ppm but are intermediates for fragments that w ere detected. 
Isomers likely exist but w ere not resolved.  
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Figure 2.S.8. Ion at m/z 878.82 identified as triacylglycerol 
CID spectrum of precursor ion 878.82 labeled w ith measured m/z values and error in 
parts per million (ppm) for matches to deduced fragments w ithin 10 ppm. The maximum 
centroid peak intensity of a single scan is show n. The dashed red line indicates the 
parent ion. Dotted blue lines indicate the masses of expected fragments based on the 
deduced chemical structure. Inset show s the chemical structure of TAG. Isomers likely 
exist but w ere not resolved.  
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Figure 2.S.9. Ion at m/z 671.466 identified as phosphatidic acid 
 CID spectrum of precursor ion 671.466 labeled w ith measured m/z values and error in 
parts per million (ppm) for matches to deduced fragments that match know n values 
w ithin 10 ppm. The maximum centroid peak intensity of a single scan is show n. The 
dashed red line indicates the parent ion. Dotted blue lines indicate the masses of 
expected fragments based on the deduced chemical structure. Inset show s the chemical 
structure of PA.  
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Figure 2.S.10. Ppm1 is a PMf protein and colocalizes with GlfT2 in vitro 
(A) Ppm1-mNG-cMyc- expressing cell lines grow  similarly to w ild-type Msmeg. Blue 
diamond, w ild type; red square, Ppm1-mNG-cMyc expressing cells; green triangle, HA-
mCherry-GlfT2 and Ppm1-mNG-cMyc dual expressing cells. Grow th of each strain w as 
measured in triplicate and standard deviations are show n. (B) Ppm1-mNG-cMyc (59.1 
kDa) protein localized to the PMf containing fractions by sucrose gradient. The PMf, 
identified by PimB’ (41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa). (C) 
Distribution of tw o PMf markers (HA-mCherry-GlfT2, 99.6 kDa, and Ppm1-mNG- cMyc, 
59.1 kDa) in a single cell line by sucrose gradient demonstrates fusion protein 
localization biochemically to the PMf-containing fractions. The PMf fractions are 
identified by the localization of PimB’ (41.4 kDa) and the PM-CW fractions are identified 
by the localization of MptA (54.3 kDa). (D) Immunoprecipitation of HA-mCherry-GlfT2 
from dual expressing (HA-mCherry-GlfT2, 99.6 kDa, and Ppm1-mNG-cMyc, 59.1 kDa ) 
cell lysate pulls dow n the other PMf proteins, endogenous PimB’ (41.4 kDa) and Ppm1-
mNG-cMyc (59.1 kDa), but not the PM-CW marker MptA (54.3 kDa).  
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Figure 2.S.11. Fluorescent fusion proteins show the localization of the PMf and the 
PM-CW 
(A) Biochemical analysis of the fluorescent protein localizations show  that both the 
mTurquoise- and mCherry-labeled GlfT2 proteins (mTurQ-GlfT2-FLAG, 101.6 kDa; and 
HA-mCherry-GlfT2, 99.6 kDa) localize to the PMf-containing fractions. The PMf, 
identified by PimB’ (41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa). (B) 
Fluorescent fusion proteins of GlfT2 (mTurQ-GlfT2- FLAG and HA-mCherry-GlfT2) 
colocalize. (C) Distribution of a PMf-associated fusion protein (HA- mCherry-GlfT2, 99.6 
kDa) and a PM-CW associated fusion protein (PimE-GFP-FLAG, 82.3 kDa) along a 
sucrose gradient demonstrates their different in vitro localizations. The PMf, identified by 
PimB’ (41.4 kDa); and the PM-CW, identified by MptA (54.3 kDa).  
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Figure 2.S.12. Autofluorescence does not account for the blue fluorescence from 
mTurquoise- GlfT2-FLAG expressing cells 
All fluorescent images w ere captured by 3 s exposures, and processed identically. Note 
that blue auto-fluorescence in w ild-type cells is negligible.  
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Figure 2.S.13. The spatiotemporal correlation of the PMf and polar CW elongation 
examined by chemical labeling of CW 
(A) New  cell envelope grow th, represented by the absence of AlexaFluor 488 amine-
reactive dye (w hite bars), correlates w ith the HA-mC-GlfT2 foci (arrow heads). Bar=5μm. 
(B) Quantitation of AlexaFluor 488 staining and HA-mC-GlfT2 foci along the cell length. 
Cell images w ere sliced into 10 sections and average fluorescent intensities of 5 slices 
from the center to the pole w ere quantified in arbitrary fluorescent units (a.u.). n=214 
cells.  
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Figure 2.S.14. Working model for the compartmentalization of glycerolipid 
biosynthesis pathways in M. smegmatis revealed by proteome and lipidome 
analyses 
 The data obtained from the proteome and lipidome w ere compiled to demonstrate one 
possible correlative interpretation of how  the enzymes and lipids can interact w ith 
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membrane compartments in mycobacteria. MSMEG_ accession numbers are indicated 
for know n or putative enzymes involved in the pathw ay. Subcellular localization of 
proteins and lipids are color-coded as indicated. AcPIM6/lipomannan 
(LM)/lipoarabinomannan (LAM) biosynthesis pathw ays are abbreviated beyond AcPIM3 
because w e identified neither the enzymes nor the lipid intermediates. PI and PE are 
major phospholipid products. Another major phospholipid species, cardiolipin, w as 
omitted because w e did not find any enzymes involved in the cardiolipin biosynthesis. 
AcPIM2 and Ac2PIM2 are w ell-established products of the PIM biosynthesis pathw ay. 
Ac2PIM1 is a minor product, w hich is not w ell-characterized. G3P, glycerol-3-phosphate; 
PA, phosphatidic acid; DAG, diacylglycerol; TAG, triacylglycerol; FA-CoA, fatty acyl-
CoA; CDP-DAG, cytidine diphosphate DAG; PPi, pyrophosphate; PI, 
phosphatidylinositol; PE, phosphatidylethanolamine; PS, phosphatidylserine. GPAT, 
glycerol phosphate acyltransferase; AGPAT, acylglycerol phosphate acyltransferase; 
PAP, PA phosphatase; DAGK, DAG kinases; TGS, TAG synthetase; Psd, PS 
decarboxylase; PimA, PimB’ and ManT, mannosyltransferases; Man AcylT, mannose 
acyltransferase; and Ino AcylT, inositol acyltransferase.  
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Figure 2.S.15. Plasmid maps of those used in this study 
 
(A) Expression vectors used in this study. (B) The genomic structure of glfT2 and ppm1 
after markerless gene replacement.  
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CHAPTER 3 
STRESS-INDUCED REORGANIZATION OF A MEMBRANE DOMAIN IN 
MYCOBACTERIA 
3.1 Introduction 
Mycobacterium is a genus of actinobacteria that includes many pathogen, 
including the causative agent of human tuberculosis, Mycobacterium tuberculosis (Mtb). 
Mtb latently infects one third of the w orld’s population, w ith 1.8 million deaths reported in 
2015 alone, including 0.4 million deaths among HIV patients (1). A particular concern is 
the spreading of multi-drug-resistant strains, w hich globally account for about 4% of new  
cases and 21% of previously treated cases, highlighting a need to develop new  
chemotherapeutic strategies. An important control point of Mtb pathogenesis is the 
metabolic activities associated w ith the cell grow th as evidenced by the fact that current 
first line drugs all target enzymatic reactions critical for cell grow th. How ever, Mtb is not 
alw ays actively growing in the host. In fact, Mtb enters non-grow ing states upon 
experiencing an array of stresses from starvation to changes in pH to oxidative stress by 
reactive oxygen species (2). How  Mtb responds to these stresses, rearranges cellular 
architecture and metabolism, and persists in the host for decades remains a key 
question for the understanding of tuberculosis disease.  
The thick and w axy cell envelope of mycobacteria is a unique feature that is 
critical for the successful establishment of infection. This multilayered structure is 
composed of an inner (plasma) membrane, a cell w all w ith peptidoglycan and 
arabinogalactan, and an outer membrane made of long hydrophobic mycolic acids and 
glycolipids. This cell surface structure is thought to be the main permeability barrier 
against host immune attack and antibiotic penetration. In fact, early studies on the 
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permeability of the mycobacterial cell envelope demonstrated that it is three orders of 
magnitude less permeable to -lactam antibiotics than that of E. coli (3,4). We have 
previously shown that the structural defects in cell envelope glycolipids, lipomannan 
(LM) and lipoarabinomannan (LAM), make Mtb significantly more sensitive to -lactams 
(5). These LM/LAM mutants also failed to establish effective infection, further indicating 
the importance of the cell envelope integrity during the pathogenesis of Mtb. Others 
have also shown that mymA and fbpA mutants defective in the biosynthesis of cell 
wall mycolate-containing molecules display increased sensitivity to anti-TB drugs (6,7), 
highlighting the importance of understanding how mycobacteria create this complex 
permeability barrier.  
An interesting aspect of cell envelope elongation in Mtb as well as nonpathogenic 
model Mycobacterium smegmatis is that it only takes place at the polar ends of the cell. 
Such polar cell envelope elongation was first hinted at by polar labeling of BODIPY-
vancomycin (8,9,10). Later, polar cell envelope elongation was directly demonstrated by 
surface labeling of live mycobacterial cells with an amine-reactive Alexa Fluor 488 
fluorescent dye (11, 12)  and several cell envelope biosynthetic enzymes were found 
enriched in the subpolar zone of elongating mycobacterial cells {Meniche:2014dg}. We 
recently demonstrated the presence of a grow th pole-associated), the Plasma 
Membrane free of cell w all components (PMf) reflecting the biochemical nature of  the 
density gradient fraction containing the PMf. The PMf houses the biosynthetic capacities 
of cell envelope precursor biosynthesis including phosphatidic acid, galactan, and 
phosphatidyl inositol mannoside (PIM) biosynthesis, w hich are key steps to produce 
phospholipids, arabinogalactan, and lipo(arabino)mannan, respectively. Using 
fluorescent reporter PMf -associated proteins (mCherry-GlfT2 and Ppm1-mNeonGreen), 
w e identified the PMf at the nascent grow th pole of actively grow ing Mycobacterium 
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smegmatis cells. Our data support the role of the PMf in active polar elongation of the 
cell envelope, but it remains unknow n how  the PMf responds to non-grow ing conditions.  
In this study, w e determined that the PMf is maintained and yet reorganized in 
non-grow ing cells. Using previously published PMf reporter strains, w e tracked the in 
vivo behavior of the PMf by fluorescent microscopy during the transition from grow ing to 
non-grow ing conditions. First, w e examined the natural transition of the PMf from 
logarithmic grow th to stationary phase. and subsequently, induced nutrient deprivation to 
mimic this native progression. Second, w e tested the effects of nutrient deprivation in a 
starvation model. To determine if the PMf rearrangement is dependent on active 
peptidoglycan (PG) synthesis, w e inhibited peptidoglycan biosynthesis by chemical and 
genetic approaches. Our microscopy data, combined w ith biochemical fractionation 
analysis, suggest that the polar enrichment of the PMf is abolished in the absence of 
polar elongation, yet the membrane domain remained isolatable by sucrose density 
gradient fractionation. These results implicate that the PMf is not only important for the 
polar cell envelope elongation, but could also be important during quiescent stages 
perhaps for cell envelope maintenance and repair.  
3.2 Results  
3.2.1 The PMf relocalizes from the cell poles to the sidewall during stationary 
phase 
The PMf is a grow th pole associated membrane domain that w as first characterized in 
actively grow ing M. smegmatis cells (13, 14). We have previously reported the apparent 
loss of the PMf in late stationary phase of M. smegmatis grow th curve (13). How ever, it 
remains unclear how  long the PMf is maintained by the bacterium w hen it is no longer 
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grow ing. To begin understanding the early response of the PMf under non-grow ing 
conditions, w e monitored the localization of the PMf in early stationary grow th phase 
using the previously established PMf-reporter strain, in w hich the endogenous copies of 
the essential PMf-associated proteins GlfT2 and Ppm1 w ere replaced w ith fluorescent 
fusion proteins, HA-mCherry-GlfT2 and Ppm1-mNeonGreen-cMyc, respectively (14). As 
previously observed, at the 18-h time point in the grow th curve when the cells are under 
logarithmic grow th, the PMf markers w ere enriched at the grow th poles. How ever, w hen 
the cells entered into the stationary phase (38 h), the PMf fluorescence relocalized along 
the cell’s sidew all as cells began to divide reductively (Fig. 3.1A-B). This spatial change 
in PMf -associated proteins implied either: 1) that the PMf w as disassembled and 
proteins randomly associated w ith the conventional inner membrane (i.e. PM-CW) or 
formed aggregates w ithin the cytoplasm, or 2) that the PMf w as maintained as a 
membrane domain but spatially reorganized in the absence polar grow th. To distinguish 
betw een these tw o possibilities, w e examined the biochemical profile of the PMf-
associated proteins in a sucrose gradient (Fig. 3.1C). Cell lysate from a stationary phase 
culture (48 h time point) w as separated by density along the sucrose gradient, and w e 
found that the PMf-associated proteins continued to fraction to the PMf fractions (Fr. 4-6) 
despite the lack of active elongation of the cells. Similarly, transgenic and endogenous 
PMf protein levels remained constant w hen equal amounts of cell lysate w ere analyzed 
over the grow th cycle from log to stationary phase (Fig. 3.S.1). This implies that the PMf 
is maintained and relocalized along the sidew all possibly in response to metabolic needs 
other than polar cell envelope elongation.  
In stationary phase, mycobacteria undergo reductive cell division, in w hich cells  
continue to divide w ithout extending the cell length, creating a population of cells w ith 
shorter cell length (Fig. 3.1B). During reductive cell division, cells no longer add new  cell  
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Figure 3.1 The PMf redistributes under stationary phase and reductive division 
(A) Fluorescent images of cells grow n for the designated hours demonstrates 
reorganization of the PMf during reductive division in stationary phase. Scale bar: 5um. 
(B) Quantification of cell length over time show s reductive division from logarithmic (18h) 
into stationary phase (38h, 66h, and 88h).  N=204. (C) Western blot detection of sucrose 
gradient sedimentation to monitor the localization of PMf proteins during stationary 
phase after 48hr of grow th (PMf: Ppm1-mNG-cMyc, 59kDa; HA-mCh-GlfT2, 100kDa; 
PimB’, 42kDa; PM-CW: MptA, 55kDa) (D) Quantification of alkDD incorporation of 
stationary phase cells (OD >3.0) show s decreased de novo peptidoglycan synthesis. 
N=50. *: p<0.001. 
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envelope components at their cell poles, but continue to produce cell envelope 
components for the septum synthesis. PG is a key component of mycobacterial cell 
envelope essential for polar cell envelope elongation as w ell as septum synthesis, and 
MurG is a glycosyltransferase that mediates the synthesis of a PG biosynthetic 
precursor, Lipid II, from Lipid I. MurG is one of the proteins associated w ith the PMf 
proteome (14), and w as found enriched in the subpolar region of M. smegmatis cells 
(15). Therefore, w e speculated that the spatial rearrangement of the PMf might correlate 
w ith w here PG synthesis actively take place. To address this question, w e visualized de 
novo PG synthesis using click chemistry. We metabolically labeled another reporter M. 
smegmatis expressing HA-mCherry-GlfT2 w ith the alkyne-functionalized D-Ala-D-Ala 
dipeptide (alkDD) (16) conjugated a fluorophore by a copper catalyzed reaction using 
Alexa Fluor 488-azide, and visualized the de novo PG synthesis by fluorescent 
microscopy. Consistent w ith the active cell envelope elongation, log phase cells 
incorporated quantitatively more alkDD into their cell w all compared w ith that of 
stationary phase cells (Fig. 3.1D). Furthermore, alkDD w as predominantly incorporated 
into the actively grow ing cell pole, correlating w ith the subpolar enrichment of the PMf 
foci (Fig. 3.S.2), consistent w ith a previously published observation of PG synthesis 
during active grow th (15) In contrast, the fluorescent signal of de novo PG synthesis w as 
decreased in stationary phase, and w as more heterogeneously distributed throughout 
the sidew all of the cell (Fig 3.1.D, 3.S.2). Thus, the decrease in polar enrichment of the 
PMf during stationary phase correlated w ith the spatially rearranged nonpolar PG 
biosynthesis. 
3.2.2 Starvation induces reorganization of the PMf to the sidewalls 
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Starvation is a w ell-established model to study the stress response of 
mycobacteria (2). It is also relevant to Mtb pathogenesis, as tissue-infected Mtb in 
mouse or human patients expresses genes that are involved in adaptation to nutrient-
limitation (17). Interestingly, M. smegmatis exposed to nutrient starvation in phosphate-
buffered saline w ith Tw een-80 (PBST) continues to divide w ithout cell separation, 
resulting in filamentous morphology w ith multiple nucleoids and multiple septa (18). This 
response to PBST suggests that septum biosynthesis continues even under nutrient 
deprivation. These observations led us to question how  the PMf responds to nutrient 
deprivation in M. smegmatis. We grew  the cells expressing HA-mCherry-GlfT2 and 
Ppm1-mNeonGreen-cMyc to logarithmic phase (0 h) in normal Middlebrook 7H9 medium 
and replaced the medium w ith PBST. As expected, the cells no longer grew  upon 
nutrient depletion (Fig. 3.S.3). Consistent w ith the previous report that the starved cells 
do not undergo reductive division, the average cell length w as maintained relatively 
comparable to that of actively grow ing cells over 70 h of starvation period (Fig. 3.2A). By 
20 h starvation, the PMf foci w ere no longer enriched at the poles, but reorganized along 
the cell sidew all (Fig. 3.2A-B). The PMf remains biochemically isolatable in a sucrose 
gradient (Fig. 3.2C) even after 36 h of starvation conditions. Furthermore, the PMf 
marker proteins w ere maintained up to 48 h of starvation (Fig. 3.S.4), implicating that the 
PMf tolerates the nutrient depletion w ithout degrading the associated proteins. Finally, in 
starved cells the alkDD incorporation appeared decreased, although less severely than 
that of stationary phase, and it labeled almost exclusively septal, w ith some cells having 
multiple septa at various fluorescent intensities (Fig. 3.2C, Fig 3.S.2). Taken together, 
these data suggest that the PMf and its associated enzymes are spatially rearranged but 
maintained under tw o different non-grow ing conditions, stationary phase and starvation,  
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Figure 3.2 The PMf reorganizes along the sidewall of the cell body during PBS 
starvation 
(A) Fluorescent images of cells grow n after media replacement w ith PBS show  the 
redistribution of the PMf. Scale bar: 5µm. (B) Differences in ratio of mean fluorescent 
intensities of the cap end to the column average betw een actively grow ing (Log) and 48 
h starved (PBS) cells. N=201. (C) Western blot detection of sucrose gradient 
sedimentation to monitor the localization of PMf proteins after 30h of starvation in PBST 
(PMf: Ppm1-mNG-cMyc, 59kDa; HA-mCh-GlfT2, 100kDa; PimB’, 42kDa; PM-CW: MptA, 
55kDa) . (D) Quantification of alkDD incorporation of cell under PBS grow th conditions 
show s decreased de novo peptidoglycan synthesis. N=50. *:p<0.001. 
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potentially to support the reduced levels of non-polar cell envelope biosynthetic activities 
such as septal PG synthesis.  
3.2.3 Ongoing PG biosynthesis is necessary for the polar enrichment of the PMf  
As mentioned above, MurG is an PMf-associated glycosyltransferase involved in 
PG biosynthesis (14). Consistent w ith the association of this critical enzyme w ith the 
PMf, our results indicated that polar PMf enrichment correlates w ith polar PG 
biosynthesis. These data promoted us to test if ongoing PG biosynthesis is required for 
the enrichment of the PMf in the polar region. We inhibited PG biosynthesis chemically 
using D-cycloserine (DCS), an inhibitor of D-alanine:D-alanine ligase (19), involved in 
producing D-alanyl-D-alanine, a key substrate for the synthesis of  the pentapeptide 
precursor. When the PMf -reporter cell line w ere treated w ith DCS (40 µg/ml) for 6 h, the 
PMf foci became delocalized from the polar region, similar to the responses found under 
stationary phase and starvation (Fig. 3A-B, 3.S.5). We examined the presence of the 
PMf in a sucrose gradient and found that the PMf membrane fraction w as maintained 
after DCS-induced inhibition of PG biosynthesis (Fig. 3.3C), indicating that active cell 
envelope elongation at the pole is a prerequisite of polar PMf enrichment.  
To exclude the possibility that the rearrangement of the PMf localization is due to 
an off-target effect of DCS, w e inhibited the PG biosynthesis genetically using a 
diaminopimelate (DAP) auxotroph (20). This mutant cannot synthesize DAP, an 
essential amino acid for the formation of the peptidoglycan pentapeptide, and therefore 
requires exogenous supply of DAP. We transformed the DAP auxotroph w ith a vector to 
express an PMf marker (mTurquoise-GlfT2-FLAG) and tracked the subcellular 
localization of the PMf during logarithmic grow th in the presence of exogenous supply of 
DAP or under DAP depletion. As expected, the PMf marker w as enriched at the pole  
 79 
 
 
Figure 3.3 Cycloserine treatment inhibition of peptidoglycan synthesis leads to 
reorganization of the PMf 
(A) Fluorescent images of single cells demonstrate the relocalization of the PMf from polar 
to w hole cell enrichment after cycloserine treatment. Scale bar: 5µm. (B) Quantification of 
cap:mid ratio of cycloserine treated transgenic cells from pretreatment (Log) to 6 hours 
post treatment (DCS) demonstrates reorganization from polar to column enrichment. 
N=218. (C) Western blot detection of PMf proteins (Ppm1-mNG-cMyc, 59kDa; HA-mCh-
GlfT2, 100kDa; PimB’, 42kDa) and PM-CW protein (MptA, 55kDa) after 8hr of cycloserine 
treatment. *: p<0.001. 
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w hen the cells w ere actively elongating (Fig. 3.4B-C) and remained associated w ith the 
PMf fractions of a sucrose gradient (Fr. 4-6, Fig. 3.4A). How ever, w hen the medium w as 
depleted of DAP, the cells ceased to grow  (Fig. 3S.6). Furthermore, after 10 h of DAP 
depletion, the PMf marker relocalized along the cell sidew all (Fig. 3.4B-C). Importantly, 
the PMf fractions remained isolatable by density gradient fractionation (Fr. 4-6, Fig. 
3.4D). These observations recapitulate the results obtained using DCS, suggesting that 
PG biosynthesis is a critical metabolic activity needed to sustain the polar enrichment of 
the PMf. Importantly, the PMf is spatially rearranged but maintained as the membrane 
domain w ithout substantial degradation.  
3.2.4 The polar enrichment of the PMf is restored upon reinitiation of growth 
We have so far demonstrated that the PMf reorganizes under environmental 
challenge. We next asked if the PMf restores the polar localization w hen cells w ere 
returned to favorable grow th conditions. To do this, w e used an amine reactive dye to 
stain the existing cell w all of actively grow ing and starved cells (30 h in PBST), and place 
them into fresh 7H9 medium and monitored their recovery by fluorescent microscopy 
(Fig. 3.5A-B). We found that after 3 h of grow th recovery in fresh media, logarithmically 
grow n cells continued to elongate w ith an average extension of 2.8 µm  0.88 µm, w hile 
the starved cells added 1.9 µm  0.81 µm to their total cell length (Fig. 3.5B).  
To provide further insight, w e used time lapse microscopy and monitored the PMf 
in cells starved in PBST for 6 h then recovered in fresh 7H9 media (Fig. 3.5C, Movie 
S1). During the starvation, the PMf polar enrichment decreased, and the cells became 
w ider (Fig. 3.5C, Movie S1). How ever, w ithin 1 h of recovery, the cells began to 
elongate, and after 2 h, mild polar enrichment of the PMf w as visible, w ith strong polar 
localization at 3 h of recovery (Fig. 3.5C). In order to determine the location of PG  
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Figure 3.4 Genetic inhibition of peptidoglycan synthesis leads to redistribution of 
the PMf 
(A) Western blot detection of PMf proteins (mTurQ-GlfT2-FLAG, 75kDa; PimB’, 42kDa) 
and PM-CW protein (MptA, 42kDa). (B) Fluorescent images of single cells demonstrate 
the relocalization of the PMf from polar to w hole cell enrichment after 10hr of DAP 
deprivation. Scale bar: 5µm. (C) Quantification of DAP starved transgenic cells from 
pretreatment (Log) to 10 hours post treatment (DAP(-)) demonstrates reorganization 
from polar to column enrichment. N=204. (D) Western blot detection of PMf proteins 
(mTurQ-GlfT2-FLAG, 75kDa; PimB’, 42kDa) and PM-CW protein (MptA, 55kDa) after 10 
h of DAP depletion. *:p<0.001. 
 
 
 
 
 
 
 82 
synthesis in cells that are elongating w ithout polar PMf enrichment, w e probed 
recovering cells w ith HADA biorthogonal molecules of D-alanine to monitor active PG 
synthesis. We determined that during the first hour of recovery, HADA incorporation and 
cell length increased but w as not polarly incorporated w hen compared to fully recovered 
cells at 4 h (Fig. 3.5D).  In this study, w e established that the polar enrichment (cap:mid 
ratio) of actively grow ing cells is higher than that of stressed cells (Fig. 3.2-4). These 
data correlate high cap:mid ratio w ith greater elongation w hen compared w ith a low er 
(more distributed PMf) ratio w ith less elongation in a given time, suggesting the 
presence of the PMf allow s for efficient grow th at the poles.   
3.3 Discussion  
The PMf is a grow th pole-associated membrane domain in mycobacteria. Previously, w e 
demonstrated that the PMf houses an array of biosynthetic activities that are essential 
for cell envelope biogenesis (14). While a prior analysis suggested that PMf-associated 
lipid biosynthetic activities are diminished in a prolonged stationary phase culture (13), 
w e have little know ledge about how  the PMf responds to environmental stress. In this 
study, w e focused on short-term stress response and aimed to determine the nature of 
the PMf under non-elongating conditions.  
3.3.1 Stress-induced growth arrest leads to delocalization of the PMf from the 
polar region, but the PMf is maintained as a membrane domain  
During stationary phase, it is know n that mycobacteria undergo reductive cell 
division, during w hich cells no longer elongate, but continue to divide (21). We confirmed 
reductive cell division in stationary phase, and further demonstrated the spatial 
delocalization of the PMf from the pole. Importantly, the PMf w as purified from the  
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Figure 3.5 Recovery of polar PMf enrichment correlates with polar elongation 
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(A) Fluorescent images of actively grow ing (log) and starved (PBST) cells stained w ith 
AlexaFluor488 stained cell w all, and mCherry-GlfT2 PMf imaged before (0 h) and after 
(3 h) recovery in fresh 7H9 media. Scale bar: 5µm. (B) Quantification of cell elongation 
over 3 h of recovery in fresh media demonstrates that cells w ith established polar PMf 
enrichments (Log) elongate greater than those that had been starved. N=162. (C) Time-
lapse microscopy of cells expressing fluorescent PMf reporters (mCh-GlfT2 and Ppm1-
mNG) during a 6 h starvation in PBS and subsequent recovery in fresh 7H9 
demonstrates the redistribution and corresponding polar enrichment of the PMf during 
and after starvation. Scale bar: 15µm. (D) Fluorescent images of cells recovered in fresh 
media after a 6 h starvation in PBST illustrate the restoration of polar PMf localization 
(mCh-GlfT2) and PG synthesis (HADA) after 4h of recovery. Scale bar: 5µm. 
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stationary phase cells by density gradient fractionation, suggesting that it w as 
maintained as a membrane domain under the non-replicative condition. In addition, the 
level of three representative PMf-associated proteins appears to be maintained w ithout 
substantial degradation. These data suggest a role for the PMf during non-elongating 
conditions, such as reorganization and maintenance of the cell envelope for adaptation 
to environmental conditions. 
We tested starvation as another model of stress exposure in the current study. 
We used a recently published mild starvation model (18), in w hich cells are starved in 
PBST. In this model, mycobacteria continue to generate septa w ithout division, creating 
sites of cell envelope synthesis. Under this condition, w e found that the PMf is 
reorganized to the sidew all of the cell, similar to the spatial reorganization in stationary 
phase cells.  
During reductive cell division (stationary phase) and starvation, septum synthesis 
continues despite the absence of elongation. In addition, these tw o models show  that the 
PMf is maintained as a membrane domain, but spatially delocalized from the polar 
region. These data suggest that the PMf is relocated to nonpolar regions of the cell in 
the absence of polar elongation partly to support septal synthesis, w hich continues in 
both stress models.  Nonetheless, the molecular mechanisms that trigger the 
delocalization of the PMf remains unknow n. It is possible that global metabolic response 
such as stringent response controls the spatial localization of the PMf. How ever, even 
under a nutrient-replete condition, inhibition of PG synthesis by antibiotics is sufficient to 
delocalize the PMf. These data imply a connection betw een the PMf localization and PG 
synthesis, potentiating cross talk betw een these tw o systems and their localization. 
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3.3.2. The PMf is positioned adjacent to the sites of PG integration in both actively 
growing and non-growing cells 
In both starvation and stationary phase, cells w ere active in septal PG synthesis 
as determined by Click-iT metabolic labeling. While PG synthesis in stationary phase 
cells appeared to have polar incorporation, these sites w ere only found on cells that 
appeared to have recently divided by v-snapping, and this signal w as likely due to septal 
incorporation. In comparison, during starvation, only septal incorporation w as observed, 
w hich supported the earlier observation of PBST starvation causing multi-septated cells 
(18).  The PMf w as found adjacent to the site of PG synthesis in both models.  
The PMf-associated enzyme GlfT2 has been show n to localize to the subpolar 
region of actively elongating cells, and it w as next to the site of Click-iT PG labeling (15). 
A second identified PMf -associated enzyme is MurG, a glycosyltransferase involved in 
Lipid II synthesis. The presence of this protein in the PMf directly connects the 
membrane domain and PG biosynthesis w hich suggests that the PMf is responsive to 
the feedback mechanisms of this system. For example, w e previously showed the 
accumulation of the PMf at induced ectopic grow th poles after PG synthesis inhibition by 
D-cycloserine (14). In support of this correlation, in this study, w e demonstrated that prior 
to ectopic pole formation, w hen treated w ith D-cycloserine, the PMf reorganized to the 
sidew all, suggesting a signal from PG synthesis inhibition lead to the redistribution of the 
PMf.   
These current and previous observations together suggest a consensus model, 
in w hich there is a tight spatial link betw een the site of PG precursor synthesis (i.e. the 
PMf) and the site of incorporation of the nascent PG precursor to the existing cell w all. 
The PMf is not only adjacent to the septum but also present elsew here in the sidew all, 
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indicating that the multi-functional PMf is involved in metabolic activities other than PG 
biosynthesis. Other functions of the PMf during stress exposure remain to be 
determined.  
3.3.3. During recovery from non-growing stress, cells undergo initial non-polar 
growth  
Previously, our observation of PMf enrichment at ectopic grow th poles implied 
the existence of mechanisms to reconstruct the polar PMf after stress (14). Supporting 
this observation, in this study w e demonstrated that polar enrichment is recoverable after 
stress and the amount of polar enrichment appears to be correlated to grow th rate. We 
determined that cells w hich required initiation of PMf polar enrichment (PBST starved) 
elongate at 2/3 the rate of those w ith PMf enrichments (Fig. 3.5A-B). In addition, upon 
recovery after 6 h of PBST starvation, cells begin to elongate after 1 h or recovery, but 
noticeable elongation is observed after full PMf polar enrichment occurs 3 h after media 
replacement (Fig. 3.5C, Movie S1). These data suggest that the difference in the rate of 
grow th is due to the first hour after recovery during w hich the PMf is not enriched at the 
poles, and minimal elongation is visualized in the time-lapse imaging. 
In addition, initial grow th after starvation is likely not due to polar elongation, 
correlating w ith the non-polar PMf fluorescence. Our starvation and recovery data 
probed w ith HADA for PG synthesis suggest that the initial elongation is likely due to cell 
envelope incorporation along the cell body, similar to that of E. coli (Fig. 3.5D-E). 
Suggesting that PG incorporation is performed at the sidew all w hen the PMf is non-
polar. These data indicate that polar relocalization of the PMf is not a prerequisite of PG 
synthesis or envelope elongation. How ever, the polar enrichment of the PMf and PG 
synthesis correlates w ith rapid elongation.  Suggesting polar PMf enrichment may be a 
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strategy for mycobacteria to concentrate metabolic machinery so that they can achieve 
rapid and efficient grow th. Thus, upon reorganization back to polar enrichment of the 
PMf, efficient polar elongation occurs. 
3.4 Materials and Methods 
3.4.1 Cell Culture and Growth 
Transgenic Mycobacterium smegmatis cells, w ere grown in Middlebrook 7H9 
media supplemented w ith 0.05% Tw een80, 11 mM glucose, and 14.5 mM sodium 
chloride at 30˚ C shaking. Aliquots w ere collected and OD600 w as measured to track 
grow th. DAP auxotrophs w ere grow n in 7H9 supplemented w ith ADS, amino acids and 
DAP. Fluorescent DAP strains w ere grown with 50ug/ml streptomycin (Fisher Scientific). 
3.4.2 Starvation of Fluorescent Mycobacteria 
Transgenic mycobacteria w ere grow n to logarithmic phase by OD600, spun dow n, 
and resuspended in PBS supplemented w ith Tw een80. Cells w ere monitored by OD600, 
fluorescent microscopy, and total protein content at respective time points. 
3.4.3 Click-iT chemistry alkDD incorporation 
Treated M. smegmatis cells w ere grow n in medium supplemented w ith 2 mM of 
alkine-D-Ala-D-Ala (alkDD) for 15 min at 30˚ C, fixed in 2% formaldehyde, and probed for 
w ith the AlexaFluor488 picolyl azide fluorophore (LifeTechnologies: C10641) for 30-60 
min at room temperature in the dark.   
3.4.4 D-cycloserine Treatment of Fluorescent Mycobacteria  
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Cells w ere growth to logarithmic phase as described above and treated w ith D-
cycloserine to a final concentration of 40 µg/ml. Cells w ere analyzed by OD600, 
fluorescent microscopy, and total protein content. 
3.4.5 DAP mutant starvation 
DAP mutants w ere grown in 7H9 supplemented w ith ADS, amino acids, and DAP 
to logarithmic phase as described above. Cells w ere then spun dow n and resuspended 
in 7H9 supplemented w ith ADS and amino acids but not DAP. Analyses w ere performed 
10hr after media sw ap.  
3.4.6 NHS-Cell wall staining 
Treated M. smegmatis cells w ere treated w ith 5 mg/ml AlexaFluor488 Succimidyl 
Ester (LifeTechnologies: A20000) for 1min at room temperature in the dark, w ashed with 
PBS, then replaced in fresh 7H9 media at 30˚ C shaking. After 3 h of grow th, cells w ere 
fixed in 2 % formaldehyde and w ashed w ith PBS for fluorescent imaging. 
3.4.7 Fluorescent microscopy 
M. smegmatis cells w ere treated as above, 2 μl of cells w ere spotted onto a 1% 
agar pad made from Middlebrook 7H9 medium, and covered w ith a glass coverslip. A ll 
static live cell images w ere taken under identical settings (100x objective and 175 ms 
exposure for phase contrast or 3 s exposure for fluorescence), using a Nikon ECLIPSE 
E600 microscope equipped w ith ORCA-ER cooled CCD camera (Hamamatsu) and 
Openlab software 5.5.2 (Improvision). Mean fluorescence intensity of alkDD 
incorporation w as calculated using Fiji and average ± standard deviation is indicated. 
Polar enrichment w as measured using a custom MATLAB program that measures w ith 
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mean fluorescent of the pixels at the cap (designated as 10 pixels from the polar end) 
compared to the average column pixel intensity (intensity of total cell minus the identified 
cap ends). 
3.4.8 Protein Degradation Analysis 
Cells w ere grown as described above. At timepoints, cells w ere collected by 
centrifugation, w ashed w ith HEPES buffer, and resuspended in Bead Beating Buffer. 
Cell lysate w as made by bead beating, follow ed by analysis by BCA assay. Equivalent 
protein amounts (40 µg) of total protein w as loaded per lane, and analyzed by w estern 
blot analysis. 
3.4.9 Density gradient fractionation 
  Log phase cells (OD600 = 0.5-1.0) w ere pelleted, w ashed in 50 mM Hepes (pH 
7.4) buffer and resuspended in lysis buffer (25 mM Hepes, pH 7.4, 20% Sucrose, 2 mM 
EGTA, and a protease inhibitor cocktail) at 1 g w et pellet to 5 ml lysis buffer. Cell 
suspension w as then subjected to nitrogen cavitation at ~2250 psi for 30 min three 
times. Lysate w as spun at 3220x g for 10 min at 4°C tw ice before loaded on a 20-50% 
sucrose gradient. Gradients w ere spun at 218,000x g for 6h at 4°C, fractionated into 1 ml 
fractions, and used for further biochemical analyses. 
3.4.10 SDS-PAGE and western blotting 
Protein samples w ere mixed w ith a reducing sample loading buffer, denatured on ice, 
and run in a 12% SDS-PAGE gel. Proteins w ere transferred to a PVDF membrane 
(BioRad), blocked in 5% milk in PBST20 (PBS w ith 0.05% Tw een 20). Membranes w ere 
incubated w ith primary antibodies (anti-HA (Sigma), anti-PimB’ (7), and anti-MptA (7)) at 
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1:2000 dilutions, w ashed in PBST20, and incubated w ith horseradish peroxidase-
conjugated secondary antibodies (Sigma) at 1:2000 dilutions. Blots w ere w ashed again 
in PBST20 and developed for chemiluminescence. Images w ere recorded using an 
ImageQuant LAS 4000mini (GE Healthcare). For w estern blotting of sucrose gradients, 
an equal volume of each fraction w as loaded into the gel. All experiments w ere repeated 
at least tw ice. 
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 3.5 Supplemental Figures 
 
Figure 3.S.1. PMf protein markers are maintained from logarithmic to stationary 
phase 
PMf proteins (Ppm1-mNG-cMyc, 59kDa; HA-mCh-GlfT2, 100kDa; PimB’, 42kDa) are not 
degraded relative to PM-CW marker MptA (55kDa) from equivalent amounts of w hole 
cell lysate. 
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Figure 3.S.2. Peptidoglycan synthesis remains distinct from PMf localization in 
active growth, stationary phase, and PBS starvation 
Logarithmically grow ing cells have alkDD incorporation at the cell poles w ith subpolarly 
enriched PMf fluorescence. During stationary phase, the PMf redistributes and 
peptidoglycan synthesis decreases. When starved, the PMf relocalizes along the cell 
column yet peptidoglycan synthesis is concentrated at the septa. Green: alkDD-AlxF488. 
Red: mCh-GlfT2. Scale bar: 5µm. 
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 Figure 3.S.3. PBST starvation causes growth arrest  
 Grow th curve of cells after media replacement w ith either PBST (starvation) or fresh 
7H9 Middlebrook media (control). N=3. 
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Figure 3.S.4. PMf protein markers are maintained from during starvation 
PMf proteins (Ppm1-mNG-cMyc, 59kDa;  HA-mCh-GlfT2, 100kDa; PimB’, 42kDa) are 
not degraded relative to PM-CW marker MptA (55kDa) from equivalent amounts of 
w hole cell lysate. 
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Figure 3.S.5. Cycloserine treatment causes growth arrest 
Grow th curve and CFU’s of cells treated w ith 0, 40, and 80 µg/ml of cycloserine to 
demonstrate the sublethal dosage of drug. N=3.  
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Figure 3.S.6. DAP depletion causes growth arrest in auxotrophic M. smegmatis  
Grow th curve of cells upon media replacement w ith (+) and w ithout DAP(-) demonstrates 
the effects of DAP removal. N=3. 
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CHAPTER 4 
DISCUSSION 
The PMf is a multifunctional membrane domain associated w ith rapid grow th in 
mycobacteria. It represents the first described metabolically active membrane domain in 
mycobacteria and is likely to be essential for cell grow th and survival. The w ork 
presented has established the PMf as a dynamic membrane domain that is responsive 
to the grow th status of the cell. In addition, the data suggests a tight relationship of the 
PMf w ith the mycobacterial grow th machinery, the elongation complex and divisome.  
In Chapter 2, w e established that the PMf is the site of cell envelope precursor 
biosynthesis w ith key peptidoglycan, arabinogalactan, PIM, and phospholipid enzymes 
identified in proteomic analyses. Supporting these observations, lipidomic analysis 
determined that the lipidic products of the PIM and phospholipid pathw ays were PMf 
enriched. These processes are essential for cell survival and grow th suggesting that the 
PMf is necessary for the mycobacterial cell. In addition, Chapter 2 established that the 
PMf associated w ith nascent grow th poles, both native and ectopically induced. Chapter 
3 validated the PMf as a dynamic membrane domain that is closely linked to the 
physiological state of the cell. We demonstrated that the PMf is reorganized in the 
absence of active polar elongation, but is polarly recovered upon reinitiation of polar 
grow th. Furthering this observation, w e determined that this relocalization w as correlated 
w ith changes in PG synthesis. We presented evidence for reduced PG synthesis 
correlating w ith a reorganized PMf as w ell as adjacent location of the PMf in relation to 
PG during both polar elongation and septum formation. 
Therefore, the PMf is likely to be spatially coordinated to support polar envelope 
elongation, septal synthesis, and possibly other metabolic activities such as envelope 
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maintenance and repair. Our data support the idea that the PMf assists in cell envelope 
grow th and maintenance. How ever, these data also suggest a complex relationship 
betw een the PMf and the elongation complex and divisome. As cell envelope synthesis 
requires concurrent biosynthetic activities of many enzymes, in the spatially restricted 
areas of the grow th pole and the midcell, it can be inferred that spatiotemporal regulation 
of these processes must exist. This, in addition to the Click-iT chemistry data suggesting 
that the PMf is adjacent to peptidoglycan incorporation imply that the PMf is spatially 
excluded from the elongation complex and divisome. Nonetheless, the PMf is likely 
energetically necessary for their function as the PMf produces the precursors need by 
both complexes. These data suggest an important role of the PMf in cell elongation and 
division; thus, its necessity for cell survival and proliferation.  
Furthering this supposition, the time-lapse microscopy of recovering starved cells 
suggests that non-polar elongation is occurring during the first hour. In addition, w hen 
these recovering cells re-establish their polar PMf enrichments, they have increased 
polar PG incorporation, implying that polar elongation may represent the more rapid 
grow th mechanism. This conversion from sidew all to polar elongation after recovery, 
may represent one to the first observations of a stepw ise manner of mycobacterial 
grow th, that prior to the polar establishment of the PMf and the elongation complex, the 
cells build w all wherever the machinery is located. Then after all necessary enzymes 
and substrates are concentrated at the cell pole, grow th rate accelerates through the 
more dominant grow th strategy. Further studies into the exact relationship betw een the 
PMf and these know n cell bodies are needed to fully understand the regulatory 
mechanisms that lead to their localization and the consequences on grow th. 
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APPENDIX A 
PIMB’ LOCALIZATION IN M. SMEGMATIS 
PimB’ is a peripheral membrane protein that adds a mannose to the 6-position of 
the inositol ring of phosphatidylinositol in the process of generating mannosylated 
glycolipid species (PIMs) (Guerin et al. 2009b). It is also the first published PIM 
biosynthetic marker to have confirmed localization, by both protein and biosynthetic 
capacity, to the PMf membrane fractions (Morita et al. 2005). Therefore, w e used PimB’ 
as the initial marker for the PMf. We hypothesized that PimB’ has a specific PMf 
targeting sequence that localizes the protein consistently to the PMf fractions. We 
approached this hypothesis by truncation mutant biochemical and in silico phylogenetic 
analyses. 
A.1 Truncation mutant analysis 
A related protein, PimA, w as predicted to have a positively charged membrane 
associated helix that is independent of enzymatic activity (Guerin et al. 2009a). Similar to 
PimA, PimB’ is also predicted to have a conserved surface exposed positively charge -
helix at the N-terminus (Guerin et al. 2009b). Therefore, w e designed our truncation 
study to determine if this -helix is sufficient for protein localization. The first truncation 
mutant analyzed w as SAB562, this mutant hygromycin resistant and expresses the N-
terminal sequence (N1-177, 23kDa, Fig. A.1A) of PimB’ w ith a C-teminal HA tag from the 
L5 integration site. These cells w ere grow n, lysed, and subjected to sucrose gradient 
density fractionation. Western blot analysis of this sucrose gradient illustrated the 
fraction 4-5 localization of the endogenous PimB’ (42kDa) and the cytosolic localization 
of truncated PimB’ (Fig. A.1B). The localization of the truncated protein w as confirmed 
by anti-HA antibody strong detection in fractions 1-2 (Fig. A.1B). How ever, upon closer 
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inspection of an anti-HA probing, some of the truncated, tagged protein w as localized to 
fractions 4-6, the PMf fractions. To compare, w e also generated a PimB’ C-terminal 
expressing cell line (190-382, 26.3kDa) w e determined that this truncation localized to 
the cytosol, implying either misfolding or mislocalization (FigA.1C).  
In an effort to see if protein-protein interaction betw een the N-and C-terminal 
truncations w ould assist in mutual folding and localization, w e tried to combine these tw o 
halves of the protein and looked for their localization w ithin a sucrose gradient. We 
combined samples of our N- and C-terminus unfractionated lysates, incubated at 37˚C 
for 30min, and then applied to a sucrose gradient. We found that both proteins w ere 
heavily detected in the cytosolic fractions, how ever, we were also able to detect a 
subpopulation in the PMf fractions a characteristic that w as not seen w hen the C-
terminal end w as incubated w ith buffer alone(Fig A.1D). This implies that the tw o 
proteins may have induced colocalization of their partner terminus. 
Due to the extreme natured of the first truncation (50% truncated), questions of 
proper protein folding came into question; therefore w e designed a series of milder 
truncations. We began w ith a protein that expressed 60% of PimB’ from the N-terminus 
(1-227, 30.9kDa) and confirmed its localization by sucrose gradient. We determined that 
it, like the previous truncation mutants w as heavily detected in the cytosolic fractions, 
w ith minor detection in fractions 3-4 (Fig. A.1E). This data suggests that some of the 
protein w as still able to localize to the PMf. We also generated a truncation mutant w ith 
76% (1-290, 32kDa) of the protein tagged w ith HA, using a similar expression system, 
the protein appeared to be localized to the PMf fractions w ith some overflow  of protein to 
the cytosolic fractions (Fig. A.1F). Similarly, w hen expressing a protein w ith over 90% (1-
353, 38.7kDa) of the total protein length, the mutated protein w as detected in the PMf 
fractions and the cytosolic fractions (Fig. A.1G). Thus, w e concluded that our truncation  
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Figure A.1. PimB’ truncations give insite to potential PMf binding mechanism 
(A) Maps of truncations used in to study the mechanism of PimB’ protein localization. (B) 
Western blot detection of sucrose gradient sedimentation of cells expressing truncations  
of the N-terminus (B, 1-177, 23kDa) and the C-terminus (C, 190-382, 26.3kDa) of PimB’. 
(D) Western blot detection of sucrose gradient sedimentation of combined cell lysates 
containing the N - and C - termini of PimB’ show  increased protein detection in PMf 
fractions. (E) Western blot detection of sucrose gradient sedimentation of cells 
expressing truncations of PimB’: 1-227 (E, 30.9kDa), 1-290 (F, 32kDa), and 1-353 (G, 
38.7kDa). 
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mutations w ere sufficient for PMf localization and further interrogation of the positively 
charged helix w ould answ er more questions. 
A.2 Homology analysis 
Using the same comparison to M. smegmatis PimA, w e generated point mutant 
cell lines w ith changes in the positively charged amino acids on the proposed targeting 
-helix. On the helix, the endogenous PimB’ has a RMK94 sequence, but w e mutated 
the sequence for AMA94, replacing the charged amino acids w ith alanine residues (Fig. 
A.2A/B). This protein w as expressed using a heat shock promoter, suggesting its 
overexpression, w e were then unable to determine if the mislocalization to the cytosolic 
fractions w as due to over expression or true mislocalization. Although, the mutated 
protein w as detected in fractions 1-5 w hich would imply an alteration in PMf localization, 
the presence of the mutated protein in the PMf fractions w ould imply some fraction of the 
population properly localizing. The detection of the protein in fractions 4-5 lead us to 
conclude that this set of mutations w as not sufficient to mislocalize the protein, and the 
cytosolic localization w as due to overexpression. Indeed w hen we express full length 
PimB’ w ith an HA epitope tag using the same promoter, w e see a similar distribution. 
A.3 Discussion 
While this data demonstrated that overexpression of PimB’ lead to altered 
localization, this compiled data presents more questions. For example, is the 
mislocalization of these mutant PimB’s altered because there are limited binding sites for 
PimB’ at the PMf? Or, is there something that happens during the overexpression that 
leads to decreased affinity for the PMf? Can the mutant PimB’s compete w ith PimB’ at 
the PMf? 
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Figure A.2 Mutation of proposed localization patch of PimB’ does not affect PMf 
enrichment. 
 
(A) Amino acid sequence of the proposed positively charged sequence of w ildtype PimB’ 
(orange box) compared to the mutated sequence used in this study (red letters). (B) 
Western blot analysis of MsPimB’ (AMAR) expressing cell lysate separated by sucrose 
gradient demonstrates the enrichment of the mutant protein (43kDa) in the PMf fractions 
similar to that of the endogenous PimB’ (42kDa). 
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One clear distinction betw een the truncation experiments and the point mutants 
remains, the truncation mutants have qualitatively more signal detected in the cytosolic 
fractions than the PMf fractions. Therefore, more research into the probing the proposed 
helix might still reveal information about the targeting of PimB’ because w e have yet to 
remove all of the positive charges on the helix. 
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APPENDIX B 
GLFT2 LOCALIZATION TO THE PMF 
GlfT2 is an essential and conserved protein that is responsible for the cytosolic 
biosynthesis of the galactan chain of the arabinogalactan cell w all (Mikušová et al. 
2000). Previously, GlfT2 w as identified as a PMf protein by proteomics and fluorescently 
labeled for in vivo localization studies (Hayashi et al. 2016). It has also been proposed 
that a series of positively charged amino acids w as responsible for the membrane 
association of GlfT2 (Wheatley et al. 2012). We hypothesized that this surface-exposed 
positive patch of GlfT2 w as conserved among GlfT2 homologues and that altering this 
patch w ould alter the localization of the protein. 
B.1 Surface exposed residues of GlfT2 are conserved 
The highly related M. tuberculosis and M. smegmatis both have GlfT2 proteins 
that contain an identified series of 6 positively charged amino acids (Wheatley et al. 
2012). We then aligned the sequences of M. tuberculosis and M. smegmatis GlfT2 w ith 
those of Mycobacterium marinum, Norcardia, and Corynebacterium glutamicum (Fig. 
B.1A). We found that all of these species had similar patch areas, w ith some variation 
betw een positively charged residues, or some like Norcardia (the most distantly related), 
having multiple negatively charged residues w ithin the sequence. We also took the 
crystal structure of the M. tuberculosis GlfT2 and imaged the protein using PyMol, 
highlighting the proposed residues (Fig. B.1B), w e determined that the identified amino 
acids w ere surface exposed. 
B.2 C. glutamicum GlfT2 localizes to the M. smegmatis PMf 
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Figure B.1. GlfT2 has conserved positively charged, surface exposed amino acids 
in mycobacteria and close relatives. 
(A)Comparison of the positive patch of GlfT2 across five actinomycetes. Black: 
conserved, Purple: positively charged, Red: negatively charged, Green: no charge. (B) 
PyMol illustration of M. tuberculosis GlfT2 colored and labeled amino acids represent the 
proposed positively charged patch. (C) C. glutamicum GlfT2 (Cg3191-HA) expressed in 
M. smegmatis demonstrates PMf localization as predicted. 
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Under the assumption that the interspecies GlfT2 proteins w ould have similar 
binding targets, w e expressed C. glutamicum GlfT2 (Cg3191) w ith an HA epitope tag in 
M. smegmatis. We monitored the localization of this exogenously expressed protein by 
sucrose gradient and w estern blot (Fig. B.1C). Cg31910-HA colocalized w ith 
endogenous MsPimB’ in fraction 4-6 and not w ith endogenous MsMptA in the PM-CW 
fractions. 
B.3 Discussion 
We proposed that closely related actinomycete species w ould have a PMf similar 
to that of M. smegmatis; therefore, an essential PMf enzyme such as GlfT2 w ould 
behave similarly among these related species. We identified similarity of a proposed 
positively charged patch of amino acids on the protein surface among the species. We 
validated this concept by expressing the C. glutamicum form of the protein in M. 
smegmatis w here it localized to the PMf. As C. glutamicum is not a mycobacterium, but 
closely related, w e suggest that species that are more closely related to M. smegmatis 
such as M. tuberculosis and M. marinum w ould also have a similar PMf. Further studies 
into the interspecies similarities of the PMf should be used to identify the targeting 
sequence of PMf proteins. 
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APPENDIX C 
M. TUBERCULOSIS PMF PROTEIN EXPRESSION IN M. SMEGMATIS 
Furthering an effort to look for a targeting signal for the PMf, w e chose a small 
consortium of identified PMf proteins w ith homologues in M. tuberculosis to express M. 
smegmatis. Under the assumption that the PMf assists in polar elongation, w e reasoned 
that M. tuberculosis would likely have a biologically similar membrane domain and as 
such, protein homologues betw een the tw o species would likely behave similarly. We 
hypothesized that the M. tuberculosis PMf homologues w ould have a similar binding 
target to their M. smegmatis counterparts, and that using this information, a common 
targeting sequence w ould be found betw een the interspecies partners. 
C.1 M. tuberculosis GlfT2 localizes to the M. smegmatis PMf 
Using a similar strategy to our M. smegmatis PMf proteome biochemical 
confirmation, w e cloned M. tuberculosis GlfT2 into an integration vector that tagged w ith 
an HA-epitope. We then tracked its localization w hen this cell lysate w as subjected to 
sucrose gradient sedimentation. We determined that MtbGlfT2-HA w as enriched in 
fractions 4-6, similar to that of endogenous MsPimB’ (Fig. C.1A). This pattern w as 
similar to other overexpression data of MsGlfT2-HA (generated by DL) w hich showed a 
heavy enrichment in the PMf fractions, w ith leakage into the surrounding fractions. 
C.2 M. tuberculosis GlnA1 does not localize to the PMf in M. smegmatis 
Similar to the MtbGlfT2 expression described above, w e also interrogated the 
PMf’s relationship to glutamine synthase (GlnA1) of M. tuberculosis. We found, like the 
M. smegmatis GlnA1 (Hayashi et al. 2016), MtbGlnA1-HA is enriched in fractions 2-3,  
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Figure C.1 Expression of M. tuberculosis proteins in M. smegmatis cells mimics 
behavior of M. smegmatis PMf proteins 
 
Western blot detection of sucrose gradient sedimentation analysis of M. smegmatis cell 
lysate expressing M. tuberculosis proteins demonstrates that MtbGlfT2-HA (A, 75kDa), 
and MtbPyrD-HA (D, 37kDa) localize to the PMf, w hile MtbGlnA1-HA (B, 54kDa) and 
FLAG-MtbPimB’ (C, 42kDa) do not. PimB’ (PMf, 42kDa) and MptA (PM-CW, 55kDa). 
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w hich differed from the endogenous MsPimB’, w hich maintained in fractions 4-6 (Fig. 
C.1B). 
C.3 M. tuberculosis PimB’ does not localize to the M. smegmatis PMf 
In addition, w e analyzed M. tuberculosis PimB’ expression in M. smegmatis. After 
many failed attempts at cloning PimB’ w ith a C-terminal HA-epitope tag, w e expressed 
the protein w ith an N-terminal FLAG epitope. Unfortunately, unlike MtbGlfT2 and 
MsPimB’, MtbPimB’ w as localized to the cytosolic fractions (Fig. C.1C). How ever, the 
FLAG tag sequence is DYKDDDDK, a very negatively charged peptide. While this did 
not alter the localization of mTurQ-GlfT2-FLAG, putting a negatively charged tag at the 
N-terminus of MtbPimB’ may have interfered w ith its membrane targeting. As w e 
introduced in Appendix A, MsPimB’ localization is accredited to a positively charged 
helix on its N-terminal half; therefore, the location of the FLAG tag may have greatly 
affected the protein’s localization. 
C.4 M. tuberculosis PyrD localizes to the PMf in M. smegmatis  
Finally, w e analyzed M. tuberculosis PyrD-HA localization w hen expressed in M. 
smegmatis. We observed that similar to the M. smegmatis homologue, MtbPyrD-HA is 
enriched in the PMf fractions (4-6), and some is localized to the PM-CW fractions (Fig. 
C.1D). While detection in the PM-CW fractions, may pose a conundrum, w e posit that 
PyrD has a single transmembrane domain w hich holds it to the membrane. Therefore, 
w hen overexpressed, the MtbPyrD-HA is enriched in the PMf as properly targeted 
protein, but the rest of the overexpressed protein is pushed into the canonical plasma 
membrane, part of the PM-CW.  
C.5 Discussion 
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The expression of M. tuberculosis PMf proteins in M. smegmatis suggests that 
the targeting PMf targeting signal is similar betw een the tw o species. While the PimB’ 
exogenous expression system did not result in PMf localization, it may be an 
experimental system to revisit since the chosen epitope tag may have been the root 
cause of mislocalization. How ever, PimB’ has been rather recalcitrant to alterations, as 
attempts to fluorescently label PimB’ have resulted into protein aggregates that pellet 
out, potentially making PimB’ a non-ideal candidate for modification. The other M. 
tuberculosis proteins behaved like their M. smegmatis homologues w hich suggests that 
1) a common targeting signal exists and 2) M. tuberculosis likely has a PMf. Further 
studies looking at potential targeting signals, like the PyrD transmembrane domain or the 
GlfT2 positive patch should be continued. 
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APPENDIX D 
MYCOWORLD 
The PMf is a grow th pole associated membrane domain in M. smegmatis and is 
suggested to assist in the controlled elongation. Since mycobacteria elongate from their 
poles, w e hypothesized that other species of mycobacteria w ould also have PMf 
membrane domains. To address this hypothesis, w e performed sucrose gradient density 
fractionation on lysates from pathogenic mycobacteria. 
D.1 M. avium has PMf protein and lipid separation 
Wildtype M. avium cell lysate w as processed through a sucrose gradient and 
subsequent w estern blot analysis under the assumption that strong protein homology 
w ould allow  for cross reactivity and detection. We found that M. avium had very strong 
PMf protein detection like that of M. smegmatis, w ith PimB’ detection in fraction 4-5 and 
MptA detection in fractions 8-12 (Fig. D.1A). We then analyzed the lipid distribution of 
the M. avium sucrose gradient and found and enrichment of PIMs in the PM-CW 
fractions (Fig. D.1B), similar to that of M. smegmatis. In addition, using cell-free, 
radiolabeling of GDP-mannose, w e demonstrated that AcPIM2 synthesis w as only 
present in fractions 5-6, the PMf fractions (Fig. D.1C). PCR confirmation of the M. avium 
sample w as not confirmed. 
D. 2 BCG has PMf protein separation 
Similar to the M. avium PMf analysis, BCG cell lysate w as analyzed by sucrose 
gradient looking for cross reactivity w ith antibodies raised against M. smegmatis  
endogenous proteins. We found that BCG had w hat appeared to be PimB’ cross reactive 
bands at the right size and in fractions 4-5; how ever, bands in fractions 1-2 w ere very  
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prominent and prevented conclusion that BCG PimB’ w as localized to the PMf (Fig. D.2). 
In addition, w e were unable to detect MptA by cross reactivity w ith the MsMptA antibody. 
D.3 M. tuberculosis has PMf protein and lipid separation 
M. tuberculosis lysate was analyzed via sucrose gradient sedimentation and 
w estern blot. We identified potential MtbPimB’ bands in fractions 4-5; how ever, there 
w as very strong bands in the cytosolic fractions implying that these bands could be non-
specific (Fig. D.3A). We w ere unable to detect cross reactivity of the MsMptA antibody 
w ith MtbMptA (Fig. D.3A). Despite the uncertainty generated by the w estern blot 
analyses, lipid analysis of the M. tuberculosis sucrose gradient samples demonstrated 
clear separation of PIM species (Fig. D.3B). AcPIM6 w as detected only in the predicted 
PM-CW fractions of 8-13, w hich substantiates the likelihood that M. tuberculosis has a 
PMf. Cell-free radiolabeling w ith GDP-mannose demonstrated the biosynthesis of PPM 
w as restricted to fraction 3, and 13 (Fig. D.3C). 
D.4 Discussion 
This preliminary study on non-M.smegmatis mycobacteria suggests that the PMf 
is present in other Mycobacterium species. Complete biochemical analyses of these 
pathogenic mycobacteria should be performed to give insight into the phylogenetic 
significance of the PMf. Further studies of cell-free radiolabeling should be continued, 
the M. tuberculosis study was performed using a 90min incubation, but a longer 
incubation time might be necessary for the slow  growing species. In addition, I 
generated a cell line expressing MtbPyrD-HA on an integrative plasmid and this should 
be used to further dissect the M. tuberculosis PMf.  
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Figure D.3. M. tuberculosis has PMf protein and lipid separation 
(A) Western blot analysis of M. tuberculosis sucrose gradient fractions demonstrates 
potential PimB’ localization in the PMf fractions 4-5, upper panel. MtbMptA w as not 
detected using MsMptA antibodies, low er panel. (B) Lipid extraction and detection by 
orcinol demonstrates differential distribution of both AcPIM2 and AcPIM6. (C) Cell-free 
radiolabeling of GDP-Mannose demonstrates PPM synthesis is restricted to fraction 4. 
UF: unfractionated/ w hole cell lysate. 
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APPENDIX E 
THE PMF AND DRUGS 
In order to dissect the relationship betw een the PMf and stress, w e probed cells 
expressing fluorescent PMf reporters w ith a variety of chemicals. The chosen chemicals 
have know n cellular targets w hich inhibit processes such as fatty acid synthesis, 
peptidoglycan synthesis, protein synthesis, and pyrimidine biosynthesis. These 
processes w ere chosen due to the know n related PMf functions, cell w all and pyrimidine 
biosynthesis, and non-PMf targets like fatty acid and protein synthesis. We hypothesized 
that PMf targeted inhibitors w ould alter the PMf localization and biochemistry like that of 
cycloserine (see Chapters 2 and 3), w hile more global inhibitors (streptomycin) w ould 
not cause immediate PMf changes. 
E.1 Fatty acid synthesis inhibition 
E.1.1 Isoniazid 
Isoniazid is a first line drug against human tuberculosis. It is processed by KatG, 
a catalase peroxidase enzyme, that binds the drug and interacts w ith InhA, an enoyl-acyl 
carrier protein reductase, thus inhibiting fatty acid synthesis. When cells w ere treated 
w ith 50 and 100 µg/ml and PMf localization observed overtime, w e noted that the PMf 
eventually relocalizes to the side w all of the cell (Fig. E.1). 
E.2 Cell wall synthesis inhibitors 
E.2.1 D-Cycloserine 
As mentioned in Chapter 2 and Chapter 3, D-cycloserine inhibits the D-alanine 
racemase and ligase, preventing the synthesis of the D-alanine-D-alanine dipeptide  
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Figure E.1. Isoniazid leads to mild alterations in PMf localization 
 (A) Isoniazid (INH) treated cells show s minimal grow th phenotype compared to 
untreated cells. N=1. Fluorescent images demonstrate the PMf fluorescent localization in 
untreated (B), INH 100µg/ml (C), and INH 50µg/ml (D). The fatty acid synthesis inhibitor 
decreases PMf polar enrichment. Scale bar: 5µm. 
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Figure E.2. D-alanine mildly rescues cells treated with D-cycloserine 
 
(A) Grow th curve demonstrates grow th inhibition by D-cycloserine from 0 to 4 hours, 
after w hich D-alanine w as added and mild rescue w as observed. N=1. 
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formation (Zygmunt. 1963, Halouska et al. 2013, Prosser & de Carvalho. 2013) In 
addition, previous studies identified D-alanine as a metabolite that could rescue the drug 
treated cells (Zygmunt. 1963, Halouska et al. 2013, Prosser & de Carvalho. 2013). 
Therefore, w e aimed to recapitulate this phenotype of our D-cycloserine treated cells to 
confirm that the concentration used w as not causing off target effects. We grew  the cells 
in the presence (40µg/ml) and absence of the drug for 4 hours, then added differing 
amounts of D-cycloserine to each flask (0.2mM, 0.1mM, 0.05mM, and 0mM) and 
monitored their recovery by OD measurements (Fig. E.2). We saw  only mild changes in 
grow th due to D-alanine addition, varying concentrations and times should be used to 
make further conclusions. In addition, once this assay is established, the PMf should be 
observed for recovery. 
E.3 Protein synthesis inhibition 
E.3.1 Streptomycin 
Streptomycin w as the first anti-tuberculosis drug, found by Dr. Selman Waksman 
in 1944, due to rapid resistance to the treatment it is now  classified as a second line 
treatment for patients w ith tuberculosis (Zumla et al. 2013b). It is an aminoglycoside that 
binds the small 16s rRNA of the 30s subunit, this prevents tRNA binding, thus 
destabilizing the complex (Sander et al.1995). Treatment w ith streptomycin halts the 
grow th of cells expressing fluorescent PMf reporters (Fig. E.3A), and also leads to the 
reorganization of the PMf markers (Fig. E.3B). This rearrangement of fluorescent 
proteins appears to cause a complete juxtaposition of the usually colocalized PMf 
markers (Fig. E.3B); thus inhibition by binding of the 30s ribosomal subunit must cause 
some alteration of the PMf protein interactions. Finally, the PMf is maintained after 8  
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Figure E.3. Streptomycin treatment leads to juxtaposition of PMf markers 
(A) Streptomycin treatment (50mg/ml) leads to a halt in grow th. N=1. (B) Fluorescent 
images demonstrate decreased colocalization of tw o PMf reporter proteins, after 
streptomycin treatment. (C) Western blot detection of sucrose gradient density 
fractionation illustrates maintenance of the PMf membrane fractions. Scale bar: 5μm 
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Figure E.4. Inhibitors that bind the 50s ribosomal subunit alter PMf localization 
 
(A) Varying concentrations of protein synthesis inhibitors slow  the grow th of M. 
smegmatis cells. N=1. Fluorescent images of cells expressing PMf fluorescent reporters 
demonstrates the changes in the PMf over time due to no treatment (B), erythromycin 
(C), and chloramphenicol (D). Scale bar: 5µm. 
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hours of streptomycin treatment as it is biochemically isolatable by sucrose gradient 
sedimentation (Fig. E.3C). 
E.3.2 Erythromycin 
 A macrolide, erythromycin halts protein synthesis by binding the 50s subunit of 
the rRNA complex, inhibits translocation of the tRNA from the A to the P site (Alvarez-
Elcoro & Enzler. 1999). Erythromycin is bacteriostatic When treated at both low  
(50µg/ml) and high (100µg/ml) of erythromycin, the PMf maintained some polar foci; 
how ever, significant amounts of the fluorescence w as seen along the cell column, but 
not colocalized (Fig. E.4A-C) 
E.3.3 Chloramphenicol 
Chloramphenicol is safe for human use because it binds the 23s rRNA of the 
bacterial 50s ribosomal subunit; thus preventing transpeptidation of nascent amino acid 
residues in prokaryotes (Weisberger. 1967). We treated cells expressing PMf fluorescent 
reporters to monitor the effects of protein synthesis inhibition on the PMf. Cells w ere 
treated w ith both 5 and 15 µg/ml of chloramphenicol, to test their responsiveness at high 
and low  drug concentration. We found that unlike streptomycin w hich saw a stark 
juxtaposition of PMf fluorescent markers, the proteins in chloramphenicol treated cells 
appear to maintain polar foci, but generally decrease in brightness along the column (Fig 
4AD). 
E.4 Pyrimidine biosynthesis inhibition 
E.4.1 Brenaquinar   
Brenaquinar is a know n inhibitor of human dihydroorotate dehydrogenase 
(DHODH) and w as used to treat leukemia by preventing pyrimidine biosynthesis (Sykes  
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Figure E.5. Brenaquinar does not inhibit bacterial growth 
 
Grow th curves of actively grow ing cells being treated w ith  Brenaquinar at 0.02-1.28µM 
(A), 3.2-12.8µM (B), and 32-128µM (C) demonstrate that  Brenaquinar does not have a 
grow th phenotype in M. smegmatis. N=1. 
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et al. 2016). Since, pyrimidine biosynthesis in M. smegmatis is performed by PyrD, a 
PMf protein, w e looked to inhibit specific activity of the PMf by chemical treatment and 
monitor the membrane domain’s response. We hypothesized that shut dow n of a PMf 
biosynthetic pathw ay would cause cell death as pyrimidine biosynthesis is an essential 
process.  
When treated w ith the effective does on human cells (20nm), the cells show ed no 
grow th phenotype (Fig. E.5.A); in fact, up to 128µm a signif icant grow th phenotype w as 
not visible (Fig. E.5.A-C). How ever, at 128µm for 9 h, a slight difference from untreated 
cells is visible, w hich could imply that some toxicity to the cell w as occurring, but after 
longer treatment that difference w as no longer present (Fig. E.5.C). It remains unknow n 
if  Brenaquinar can penetrate the multilaminar cell envelope of mycobacteria. Despite 
this fact, pyrimidine biosynthesis is an essential process in mycobacteria, and other 
inhibitors are available (Sykes et al. 2016).  Brenaquinar w as chosen for its low  effective 
dose, that w as not effective in M. smegmatis. Further studies into other inhibitors should 
be continued as potential treatments for M. tuberculosis. 
E.5 Discussion 
Chemical treatment of cells expressing fluorescent PMf reporters can be used to 
dissect the mechanisms around the PMf. In that, many of the PMf-associated enzymes 
are essential (GlfT2 and Ppm1), therefore, genetic manipulation requires complicated 
knock-dow n mechanism. How ever, probing w ith an appropriate chemical to stop the 
specific enzymatic activity w ill allow  its relationship to the PMf to be understood.  
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APPENDIX F 
M. SMEGMATIS GROWTH IN DIFFERENT MEDIA 
In an effort to look at density dependency and its influence on the PMf, I aimed to 
look at different grow th mediums to look at their effect on M. smegmatis. We 
hypothesized that at high densities, the PMf fluorescence w ould decrease. In addition, 
w e used spent 7H9 media from a high density culture to look at the effect of high cellular 
grow th w ithout increased culture density. 
F.1 The PMf is maintained in high density cultures   
 We began by grow ing M. smegmatis cells expressing tw o fluorescent PMf 
reporters (mCherry-GlfT2 and Ppm1-mNeonGreen) in different media including, Luria 
broth (LB), Mueller Hinton broth, M63 broth, Sauton’s broth, 7H9, 7H9 w ith 50% glucose 
(50%), 7H9 w ith double glucose (2x), and 7H9 w ith triple glucose (3x). We found that the 
amount of glucose supplemented into 7H9 media did not significantly affect grow th rate 
(Fig. F.1A). How ever, both M63 and Sauton’s media allow ed grow  to an OD600 
approximately 5 times greater than the 7H9 cultures. In addition, after 75 hours of growth 
in their respective media, images w ere taken of the 7H9, M63, and Sauton’s cultures in 
order to compare the PMf fluorescence. Even at very high OD, the PMf fluorescence 
w as still present and distributed (Fig. F.1B). Also, the cells grow th in Sauton’s media 
w ere consistently qualitatively longer than all other conditions. 
F.2 The PMf is responsive to conditioned media 
In order to decipher the differences betw een cell to cell contact and high cell 
density signaling molecules, w e used conditioned media at differing concentrations to 
monitor the PMf. We found that at high concentration of spent medium (100%CM) cells  
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Figure F.1. Growth medium affects cell growth 
 
(A) Grow th curve of M. smegmatis grow n in different media demonstrates the high 
culture capacity of M63 and Sauton’s media compared to 7H9 based medias. N=1. (B) 
Fluorescent images demonstrate that the PMf is maintained and reorganized in 
stationary phase after 75 hour of grow th in various media. Scale bar: 5µm. 
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Figure F.2. Spent media induces stationary like PMf phenotype 
(A) Grow th curve of cells treated w ith fresh 7H9 (7H9), PBST (PBS), 50% spent medium 
(50% CM in 7H9) and 100% spent medium (100% CM) show s the grow th inhibition of 
spent media and PBS. N=1. (B) Fluorescent images of cells treated over time illustrates 
the changes in PMf phenotype due to cell phase transitions. (C) Fluorescent images of 
cells after 3hr treatment confirms changes in peptidoglycan incorporation (HADA), due to 
altered environments. Scale bar: 5µm. 
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halt their grow th and w ithin one replication cycle the PMf is induced to a stationary 
phase-like state of distributed along the cell body (Fig. F.2A-B). Similarly, the 50%CM 
culture w hich had contained half fresh 7H9 media, grew  like the positive control 7H9 
Culture, but never reached a very high OD and w hen images appeared to have 
decreased PMf polar enrichment (Fig. F.2A-B). Interestingly, w hen a coumarin labeled 
D-alanine biorthogonal molecule (HADA) w as added to the cells after 3 hours, polar 
elongation of the 100%CM culture w as not observed (Fig. F.2C). Polar incorporation that 
w as observed in this culture appeared to be the result of recent cell division supporting 
the idea that these cells w ere beginning the process of reductive cell division, in w hich 
septa are formed and cells divide w ithout elongation (Fig. F.2C). In addition, the positive 
control of 7H9 and the negative control of PBS w ere in stark contrast to these 100%CM 
cultures (Fig. F.2C), w hile the 50%CM resembled the positive control w ith polar and 
septal incorporation of the HADA. 
F.3 Discussion 
The PMf appears to be unresponsive to culture density as it is maintained even 
at an OD greater than 15. In addition, the difference media types lead to varying cell 
morphology, as w ith the cases of M63 and Sauton’s in w hich both medias maintained 
longer cells than their 7H9 counterpart. M63 media at 48 hours of grow th had 
consistently long cells w hich decreased in size after 75 hours of grow th, very similar to 
the reductive division seen in stationary phase cell grow n in 7H9. This suggests that 
w hen in M63, the stationary grow th phase is not reached at a specified OD, but rather at 
a later stage w hen the nutrient conditions are depleted. In addition, w hen grow n in spent 
medium, the cells appear to enter into a state of induced reductive division, 
corresponding w ith their decreased grow th rate, PMf polar enrichment, and pole HADA 
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incorporation. These data suggest that grow th conditions should be considered w hen 
analyzing cells for a given question. 
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APPENDIX G 
THE PMF VS THE PM-CW IN STARVATION 
Starvation is know n to alter the PMf, causing a reorganization of the membrane 
domain w hile the cells are deprived of carbon. How ever, it remains unknow n how  this 
rearrangement of the PMf is related to the bulk plasma membrane associated w ith the 
PM-CW. We hypothesize that the PMf reorganization w ill lead to discrete patches that 
are distinct from the PM-CW. 
G.1 The PMf does not co-localize with the PM-CW during starvation 
 The PM-CW w as visualized using the fluorescent reporter PimE-GFP, the PMf by 
mCherry-GlfT2. Cells w ere grow n to logarithmic phase, then media exchanged for either 
7H9 or PBS. Then after 3.5 hours of grow th, fresh media replaced the 7H9 (control) and 
one PBS culture (recover) w hile one PBS culture w as given fresh PBS (starve). The 7H9 
culture continued to grow  throughout the experiment, w hile the continuously starved 
culture never grew  and the recovered culture began grow ing 3 hours after the media 
w as replaced (Fig. G.1A). Corresponding w ith this grow th phenotype, the control cells 
maintained their PMf foci (Fig. G.1B), the starved cells reorganized their PMf (Fig. 
G.1C), and the recovered cells reestablished their PMf enrichments after 3 hours of 
fresh media (Fig. G.1D). In all of these conditions, colocalization of the PMf and the PM-
CW markers w as not observed, indicating that these membrane domains remained 
distinct even under stress conditions.  
G.2 Discussion 
The PM-CW does not appear to be altered during these starvation conditions, 
implying that it is unresponsive to this change in environment. How ever, more studies  
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Figure G.1. The PM-CW does not change in response to starvation 
(A)Grow th curve of cells during starvation conditions. Arrow : media exchanged for 
recovery. N=1. The PM-CW does not change w hen monitored by PimE-GFP 
fluorescence w hen comparing normal grow th (B), PBS starvation (C), and recovered 
cells (D). Scale bar: 5µm. 
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should use metabolic labeling to look at the rate of active rearrangement w ithin the PM-
CW during starvation w hile monitoring the PMf phenotype. In addition, these studies 
may be altered by the fact that the PimE-GFP under the control of a heat shock 
promoter and may be overexpressed; thus, the fluorescent pattern may not be 
representative of biological levels of PimE-GFP. Adding to that, the overexpression of 
PimE may lead to an increase in AcPIM6, and lead to altered cell w all chemistry that 
w ould affect the cells response to the starvation condition. This caveat w ould again lend 
to the suggestion that metabolic labeling be performed in cells only expressing the PMf 
markers at endogenous levels. Finally, quantification of cells under these conditions 
should be completed in order to look at the overall population effect, because these 
images, w hile deemed representative still have the bias of the author behind them. 
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APPENDIX H 
THE PMF AND HYPOXIA 
During infection, M. tuberculosis experiences decreased oxygen environments, a 
condition to w hich it must adapt in order to survive. It is know n that under hypoxic stress, 
M. tuberculosis reorganizes its cell w all and membrane compositions. Our preliminary 
data suggests that M. tuberculosis has a PMf membrane domain; therefore, w e 
hypothesized that the PMf w ould reorganize under hypoxic conditions.  
H.1 The PMf reorganizes under hypoxic conditions 
In order to address our hypothesis, w e monitored the localization of the PMf 
using our cells expressing tw o PMf fluorescent reporters (mCherry-GlfT2 and Ppm1-
mNeonGreen) under normal aerated and oxygen deprived conditions. We demonstrated 
that decreased oxygen leads to a cessation of grow th in comparison to the aerated 
control (Fig1A). In addition, w hile cells maintained their PMf polar enrichment during 
aerated grow th, the hypoxic cultures maintained their polar enrichments until 11hours of 
hypoxia at w hich cells appeared shorter w ith reorganized PMf fluorescence (Fig1B). 
H.2 Discussion 
Hypoxia is know n to lead to major changes in cell w all composition in M. 
tuberculosis. This implies that major maintenance and reconstruction is occurring under 
this given stress. Therefore, the PMf reorganization may coincide w ith these cellular 
changes due to its multifunctional biosynthetic capacities. Further studies on hypoxia 
and the PMf should be used in addition w ith metabolic labeling be it radioactive or 
biorthogonal incorporation to more closely inspect the relationship of the PMf w ith sites 
of active reconstruction. 
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Figure H.1. Hypoxia leads to PMf reorganization 
(A) Grow th curve of oxygen deprived and aerated cells demonstrates that hypoxia halts 
grow th. (B) Fluorescence images of aerated (control) and oxygen deprived (hypoxia) 
illustrates the reorganization of the PMf in the absence of oxygen. Scale bar: 5µm. 
 
 
 
 
 
 137 
APPENDIX I 
APEX2 AND THE PMF 
The PMf is a multifunctional membrane domain in mycobacteria. While it is 
know n that it is biochemically isolatable and localized to the grow th poles of M. 
smegmatis, the physical structure of the PMf remains unknow n. Transmission electron 
microscopy is advantageous for imaging membrane structures w ith nanometer 
resolution; how ever, using gold-labeled antibodies for detection of specific cellular 
structures can destroy ultrastructure and can be time consuming. One alternative 
technique is the use of genetically encoded epitope tags that are expressed in the cell, 
do not required permeabilization, and are less technically demanding than the cryo-
sectioning necessary for antibody labeling (Martell. 2012). Upon the addition of hydrogen 
peroxide and the osmophilic molecule diaminobenzidine (DAB), electron dense 
precipitates can be visualized by transmission electron microscopy We hypothesized 
that using an engineered ascorbate peroxidase (APEX2) epitope tag w ill provide the 
electron density to determine the ultrastructure of the PMf. In order to address this 
hypothesis, w e tagged PMf proteins w ith the APEX2 tag, checked their localization 
biochemically, and observed their localization by transmission electron microscopy (Lam 
et al. 2015). 
I.1 APEX2 expression is not toxic to M. smegmatis 
APEX2 is an engineered ascorbate peroxidase, therefore, w e needed to 
demonstrate that expression of this exogenous protein w as not toxic to our M. 
smegmatis cells. We expressed APEX2 under the control of an acetamide inducible 
promoter and demonstrated that during the induction the cells continued to grow  and 
expressed the APEX2 protein over time. (Fig. 1.A-B). 
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Figure I.1. APEX2 expression is not toxic to the cell 
 
(A) Grow th curve demonstrates after acetamide induction OD600 continues to increase. 
Wildtype (blue), w ildtype w ith APEX2 (grey), HA-mCh-GlfT2 expressing cells w ith 
APEX2 (orange). N=1.(B) Western blot detection of FLAG-APEX2 expression is induced 
under acetamide induction. FLAG-APEX2: 28kDa. 
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I.2 Ppm1-APEX2 does not localize to the PMf biochemically 
 We also generated a cell line that expressed the previously published (Hayashi 
et al. 2016) HA-mCherry-GlfT2 and an APEX2 construct, Ppm1-FLAG-APEX2. Both 
GlfT2 and Ppm1 are both essential enzymes know n to localize to the PMf. We replaced 
the endogenous copies of these tw o proteins w ith fusion proteins, and monitored their 
localization by sucrose gradient (Fig. I.2A). While HA-mCh-GlfT2 localized to the PMf 
fractions (4-6), and Ppm1-FLAG-APEX2 localized to the cytosolic fractions (1-3). While 
the mNeonGreen labeled Ppm1 protein consistently localized to the PMf fraction, this 
FLAG-APEX2 tag appeared to be affecting the localization of the protein. Ppm1 is part of 
a protein complex, Ppm1-Ppm2, w ith Ppm2 acting as an anchoring transmembrane 
protein that holds the enzymatic partner, Ppm1, at the membrane. As discussed earlier, 
the FLAG tag is a very negatively charged peptide tag; thus, the addition of the FLAG 
tag may be preventing strong interactions w ith Ppm2, w hile still leaving Ppm1 
enzymatically active. 
I.3 MSMEG_1944-APEX2 localizes to the PMf biochemically 
MSMEG_1944 is a small (13.9kDa) transmembrane protein identified in the PMf 
proteomics performed in Chapter 2. In this study, w e tagged the protein w ith a FLAG-
APEX2-HA epitope tag and tracked its localization biochemically. We found by w estern 
blot that this tagged protein (-HA) colocalizes w ith the endogenous PimB’ in the 
sucrose gradient (Fig. I.3A). We the demonstrated that the enzymatic capacity of the 
APEX2 epitope tag w as still active after cell lysate processing by adding DAB reaction 
solution (DAB and hydrogen peroxide) into small aliquots of each fraction and w as in the 
predicted PMf fractions (Fig. I.3B). In addition, w hen fractions were spot blotted onto  
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Figure I.2. Ppm1-FLAG-APEX2 does not localize to the PMf 
 
(A) Cells expressing endogenous levels of HA-mCherry-GlfT2 (100kDa) and Ppm1-
FLAG-APEX2 (59kDa) maintain their PMf localization of mCh-GlfT2, but not Ppm1-
APEX2. 
 
 
 
 
 
 
 
 
 
 
 
 141 
PVDF membrane the enzymatic activity could be detected by the addition of enhanced 
chemiluminescence (ECL) reagents (Fig. I.3C) and by DAB reaction solution (Fig. I.3D). 
I.4 MSMEG_1944-APEX2 transmission electron microscopy shows varying 
electron density 
Upon confirmation of the biochemical localization of MSMEG_1944-APEX2, w e 
probed intact cells expressing APEX2 to monitor in vivo localization of PMf proteins. 
Cells w ere fixed with glutaraldehyde, probed w ith DAB reaction solution, and embedded 
in polymer for thin section transmission electron microscopy. Samples w ere viewed 
using a JOEL JEM-2000FX transmission electron microscope w ith a LaB6 electron 
source. Electron dense patches w ere observed on the inner leaflet of the plasma 
membrane in a small portion of the population (Fig. I.4, yellow  arrows). Many of the cells 
did not have electron density w ithin the cell, w hich may be due to the small size of the 
PMf in relation to the size of the cell and the thin sectioning at 50nm.  
I.5 Discussion 
The structure of the PMf remains unknow n. It is polarly enrich in actively grow ing 
cells and is therefore expected to be found at the poles w hen observed at the membrane 
level. APEX2 protein epitope tagging has preliminarily demonstrated that it is allow s the 
PMf proteins to properly localize biochemically, and it can thus be used as a tool to look 
at the ultrastructure of the PMf w ith optimization. While the APEX2 epitope tag has many 
advantages, this technique should be combined w ith classic immunogold antibody 
detection of specific proteins in order to confirm the observed phenotype. In addition, a 
secondary method of detecting the DAB-osmium complex w ould allow  for better 
confidence in the detection. For example, pairing the complex w ith a specific metal w ill 
allow  for atom identification and differentiation betw een the non-specific uranyl acetate 
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labeling. In addition, another method to correlate these observations w ith is Click-iT 
chemistry using an electron dense substrate rather than a fluorescent one as those used 
in this study. In conclusion, the ultrastructure of the PMf w ill give insight into the 
mechanisms of the exquisite spatial regulation of the mycobacterial grow th machinery; 
thus, variations of transmission electron microscopy should be used to determine this 
configuration. 
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Figure I.3. MSMEG_1944-FLAG-APEX2-HA localizes to the PMf biochemically and 
is enzymatically active 
 
(A)Western blot detection of cells expressing FLAG-APEX2 tagged MSMEG_1944 
demonstrates the localization to the PMf. 1944-FLAG-APEX2-HA: 47.5kDa. Chemical 
detection of active APEX2 enzyme in collected sucrose fractions in tube (B) and by spot 
blotting (C-D). ECL: enhanced chemiluminescence, DAB: diaminobenzidine buffer 
treatment. 
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Figure I.4. MSMEG_1944-APEX2 expressing cells have inner membrane patches of 
electron density 
 
Panels of this section transmission electron microscopy samples demonstrates the 
heterogeneity of cells expressing 1944-APEX2. Yellow  arrow: proposed APEX2 signal. 
Scale bar: 500nm. 
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